TWI648036B - Absorbent article - Google Patents

Absorbent article Download PDF

Info

Publication number
TWI648036B
TWI648036B TW104118140A TW104118140A TWI648036B TW I648036 B TWI648036 B TW I648036B TW 104118140 A TW104118140 A TW 104118140A TW 104118140 A TW104118140 A TW 104118140A TW I648036 B TWI648036 B TW I648036B
Authority
TW
Taiwan
Prior art keywords
colloidal
emulsion
absorbent article
region
acid
Prior art date
Application number
TW104118140A
Other languages
Chinese (zh)
Other versions
TW201545726A (en
Inventor
和田一郎
Original Assignee
日商優你 嬌美股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商優你 嬌美股份有限公司 filed Critical 日商優你 嬌美股份有限公司
Publication of TW201545726A publication Critical patent/TW201545726A/en
Application granted granted Critical
Publication of TWI648036B publication Critical patent/TWI648036B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51113Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/47Sanitary towels, incontinence pads or napkins
    • A61F13/472Sanitary towels, incontinence pads or napkins specially adapted for female use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/49Absorbent articles specially adapted to be worn around the waist, e.g. diapers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51104Topsheet, i.e. the permeable cover or layer facing the skin the top sheet having a three-dimensional cross-section, e.g. corrugations, embossments, recesses or projections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/513Topsheet, i.e. the permeable cover or layer facing the skin characterised by its function or properties, e.g. stretchability, breathability, rewet, visual effect; having areas of different permeability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51113Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control
    • A61F2013/51117Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control the lotion having skin care properties

Abstract

本發明之目的為提供一種能夠連續釋放出保護著用者肌膚之乳液且再濕性優異之吸收性物品。本發明之吸收性物品如以下所述。 An object of the present invention is to provide an absorbent article which is capable of continuously releasing an emulsion which protects a user's skin and which is excellent in rewet property. The absorbent article of the present invention is as follows.

本發明為一種吸收性物品(1),其特徵為具備液體透過性層(2)、與液體不透過性層、與吸收層(3)、與膠體乳液(6)之吸收性物品(1),其中膠體乳液(6)包含作為膠體化劑之苯乙烯系彈性體、與作為乳液之烴,複數個膠體區域(8)中,互相相鄰的2個膠體區域(8)之至少一部分中,互相相鄰的2個膠體區域(8)之2個鄰接點(13)、與在此等中間之中間點(14)、與2個鄰接點相當點(15)、與中間點相當點(16)滿足以下i)~iii)之關係,i)2個鄰接點(13)之水接觸角雙方都在85°以上,ii)中間點(14)中之水接觸角比上述2個鄰接點相當點(15)中之水接觸角大,以及iii)中間點(14)之水接觸角與中間點相當點(16)中之水接觸角的差比-3(°)大。 The present invention is an absorbent article (1) characterized by comprising a liquid permeable layer (2), a liquid impermeable layer, an absorbent layer (3), and a colloidal emulsion (6) absorbent article (1) Wherein the colloidal emulsion (6) comprises, as a colloidalizing agent, a styrene-based elastomer, and at least a part of two colloidal regions (8) adjacent to each other in a plurality of colloidal regions (8) as a hydrocarbon of the emulsion, Two adjacent points (13) of two colloidal regions (8) adjacent to each other, an intermediate point (14) in the middle thereof, a point (15) corresponding to two adjacent points, and a point corresponding to the intermediate point (16) ) satisfying the relationship of the following i) to iii), i) both water contact angles of the two adjacent points (13) are above 85°, and ii) the water contact angle in the intermediate point (14) is equivalent to the above two adjacent points The water contact angle in point (15) is large, and iii) the difference between the water contact angle of the intermediate point (14) and the water contact angle in the intermediate point (16) is larger than -3 (°).

Description

吸收性物品 Absorbent article

本發明關於一種吸收性物品。 The present invention relates to an absorbent article.

吸收性物品,例如生理用衛生棉、護墊等,經由長年累積的技術開發,已漸漸地提升基本性能,與以往相比,吸收經血等排泄物之後,外漏等較少發生,目前更進一步追求高機能化,例如具有貼近肌膚的著用感。 Absorbent articles, such as sanitary napkins and pads, have been gradually developed to improve basic performance through years of accumulated technology. Compared with the past, absorption of excretions such as menstrual blood, leakage, etc. occur less frequently. The pursuit of high performance, for example, has a sense of closeness to the skin.

且,例如引證1中記載一種吸收性物品,其係在頂部薄片之外表面中的至少一部份包含有效量的乳液塗覆,該乳液塗覆在20℃下為半固體或固體,且能夠部分地移動到著用者的肌膚。且,上述乳液塗覆中包含:10~95%之(i)在20℃下具有可塑性或流動一致性,並包含選自石油基底之柔軟劑、脂肪酸酯柔軟劑、烷基乙氧基化柔軟劑、以及此等之混合物中的1種,且實質上不包含水分之柔軟劑、與5~90%之(ii)能夠將柔軟劑固定在頂部薄片的外表面上之固定化物質,且前述固定化物質具有至少35℃,較佳為至少40℃之融點,並選自多元羥基脂肪酸酯、多元羥基脂肪酸醯胺、C14-C22脂肪醇、C12-C22 脂肪酸、C12-C22脂肪醇乙氧酸鹽、以及此等之混合物。 And, for example, the absorbent article of claim 1 is characterized in that at least a portion of the outer surface of the top sheet comprises an effective amount of an emulsion coating which is semi-solid or solid at 20 ° C and capable of Partially moved to the user's skin. Moreover, the above emulsion coating comprises: 10 to 95% (i) having plasticity or flow consistency at 20 ° C, and comprising a softener selected from a petroleum base, a fatty acid ester softener, an alkyl ethoxylation a softening agent, and one of such a mixture, and a softening agent that does not substantially contain moisture, and 5 to 90% of (ii) an immobilizing substance capable of fixing the softening agent to the outer surface of the top sheet, and The immobilized substance has a melting point of at least 35 ° C, preferably at least 40 ° C, and is selected from the group consisting of polyhydroxyalkanoates, polyhydroxy fatty acid decylamines, C 14- C 22 fatty alcohols, C 12- C 22 fatty acids, C 12- C 22 fatty alcohol ethoxylate, and mixtures of these.

[先前技術文獻] [Previous Technical Literature] [引用文獻] [Citation]

[引證1]日本特表平10-509896號公報 [Citation 1] Japanese Special Report No. 10-509896

引證1中,具有35℃以上之融點的固定化物質由於在乳液塗覆中於室溫(25℃)下會結晶化,乳液塗覆的黏度會升高,具有使乳液塗覆不動化之作用。 In Citation 1, an immobilized material having a melting point of 35 ° C or higher is crystallized at room temperature (25 ° C) in emulsion coating, and the viscosity of the emulsion coating is increased, and the emulsion coating is immobilized. effect.

然而,使用固定化物質使乳液塗覆不動化(高黏度化)的話,本身就存在著有效成分之「柔軟劑」會難以從乳液塗覆中釋出的問題點。且,即使將乳液塗覆不動化(高黏度化),在體壓等高壓力之下,乳液塗覆會移動至吸收性物品的內部(頂部薄片之纖維的空隙等),會有「柔軟劑」難以持續對著用者的肌膚產生作用之問題點。 However, when the immobilized material is used to imprint the emulsion (high viscosity), there is a problem that the "softener" of the active ingredient is difficult to release from the emulsion coating. Moreover, even if the emulsion is coated immovable (high viscosity), under the high pressure such as body pressure, the emulsion coating moves to the inside of the absorbent article (the void of the fibers of the top sheet, etc.), and there is a "softener". It is difficult to continue to have problems with the user's skin.

因此,本發明之目的為提供一種能夠連續釋放出保護著用者肌膚的乳液,且再濕性優異之吸收性物品。 Therefore, an object of the present invention is to provide an absorbent article which can continuously release an emulsion which protects the skin of a user and which is excellent in rewet property.

本發明者們發現一種吸收性物品,其係具備:具有肌膚接觸區域以及肌膚不接觸區域之液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層、與膠體乳液,並具有厚度方向之吸收性物品,其特徵為上述膠體乳液中包含作為膠體化劑之聚苯乙烯系嵌段、與作為乳液之烴,且上述液體透過性層在上述肌膚接觸區域中具有:具有上述膠體乳液之複數個膠體區域、與不具有膠體乳液之非膠體區域,且上述肌膚不接觸區域中具有分別與上述複數之膠體區域以及上述非膠體區域在上述厚度方向重複的複數個膠體區域重複域以及非膠體區域重複域,上述複數個膠體區域當中,互相相鄰的2個膠體區域之至少一部中,互相相鄰的2個膠體區域之互相最近的點之2個鄰接點、與在該2個鄰接點之中間,且存在於上述非膠體區域之中間點、與上述2個鄰接點之在上述厚度方向重複,且存在於上述膠體區域重複域之2個鄰接點相當點、與上述中間點之在上述厚度方向重複,且存在於上述非膠體區域重複域之中間點相當點具有以下i)~iii)之關係,i)2個鄰接點的水接觸角,其雙方都在85°以上、ii)上述中間點中之水接觸角比上述2個鄰接點相當點中之水接觸角大、以及iii)上述中間點之水接觸角與上述中間點相當點之水接觸角的差比-3(°)大。 The present inventors have found an absorbent article comprising: a liquid permeable layer having a skin contact region and a skin non-contact region, and a liquid impermeable layer, and the liquid permeable layer and the liquid impermeable layer; The absorbent layer, the colloidal emulsion, and the absorbent article having a thickness direction, wherein the colloidal emulsion comprises a polystyrene block as a colloidalizing agent and a hydrocarbon as an emulsion, and the liquid permeable layer is The skin contact area has a plurality of colloidal regions having the colloidal emulsion and a non-colloidal region having no colloidal emulsion, and the skin non-contacting region has a plurality of colloidal regions and the non-colloidal region respectively at the thickness a plurality of colloidal region repeating domains and a non-colloidal region repeating region in which the direction is repeated, wherein at least one of the two colloidal regions adjacent to each other among the plurality of colloidal regions and the two colloidal regions adjacent to each other are closest to each other Two adjacent points, in the middle of the two adjacent points, and exist in the middle of the non-colloidal area And the two adjacent points are overlapped in the thickness direction, and are present at two adjacent points of the colloidal region repeating region, overlap with the intermediate point in the thickness direction, and exist in the non-colloidal region repeating domain The intermediate point has the following relationship i) to iii), i) the water contact angle of two adjacent points, both of which are above 85°, ii) the water contact angle in the intermediate point is higher than the above two adjacent points The water contact angle in the point is large, and iii) the water contact angle of the intermediate point is larger than the water contact angle of the intermediate point by -3 (°).

本發明之吸收性物品能夠連續釋放出保護著用者肌膚的乳液,且再濕性優異。 The absorbent article of the present invention can continuously release an emulsion that protects the skin of the user, and is excellent in rewet property.

1‧‧‧吸收性物品 1‧‧‧Absorbables

2‧‧‧頂部薄片 2‧‧‧Top sheet

3‧‧‧吸收體 3‧‧‧ absorber

4‧‧‧側邊薄片 4‧‧‧Side sheet

5‧‧‧壓印部 5‧‧‧ Imprinting Department

6‧‧‧膠體乳液 6‧‧‧colloidal emulsion

7‧‧‧肌膚接觸區域 7‧‧‧ Skin contact area

8‧‧‧膠體區域 8‧‧‧colloidal area

9‧‧‧非膠體區域 9‧‧‧ Non-colloidal area

10‧‧‧肌膚不接觸區域 10‧‧‧ Skin contact area

11‧‧‧膠體區域重複域 11‧‧‧colloidal region repeat domain

12‧‧‧非膠體區域重複域 12‧‧‧ Non-colloidal region repeat domain

13‧‧‧鄰接點 13‧‧‧ Adjacent points

14‧‧‧中間點 14‧‧‧ intermediate point

15‧‧‧鄰接點相當點 15‧‧‧The neighboring point is quite a bit

16‧‧‧中間點相當點 16‧‧‧The middle point is quite a bit

17‧‧‧乳液 17‧‧‧ Emulsion

[圖1]圖1表示根據本發明實施形態的1個吸收性物品1之平面圖。 Fig. 1 is a plan view showing an absorbent article 1 according to an embodiment of the present invention.

[圖2]圖2表示圖1之區域A的II-II剖面之剖面圖。 Fig. 2 is a cross-sectional view showing a section II-II of the area A of Fig. 1.

[圖3]圖3是用來說明本發明效果之模式圖。 Fig. 3 is a schematic view for explaining the effects of the present invention.

[圖4]圖4表示根據有別於本發明實施形態之吸收性物品1的平面圖。 Fig. 4 is a plan view showing an absorbent article 1 according to an embodiment of the present invention.

[圖5]圖5為圖4之區域A的擴大圖。 FIG. 5 is an enlarged view of a region A of FIG. 4. FIG.

[圖6]圖6是用來說明有別於本發明之實施形態之吸收性物品1的部分平面圖。 Fig. 6 is a partial plan view for explaining an absorbent article 1 different from the embodiment of the present invention.

[實施發明之形態] [Formation of the Invention]

針對本發明之吸收性物品,進行以下詳細說明。 The absorbent article of the present invention will be described in detail below.

本發明之吸收性物品具備:具有肌膚接觸區域以及肌膚不接觸區域之液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層、與膠 體乳液,並具有厚度方向。 The absorbent article of the present invention comprises: a liquid permeable layer having a skin contact region and a skin non-contact region; an absorbing layer between the liquid permeable layer and the liquid permeable layer and the liquid opaque layer; Body lotion with a thickness direction.

[膠體乳液] [colloidal emulsion]

上述膠體乳液中包含作為膠體化劑之聚苯乙烯系嵌段、與作為乳液之烴。 The above colloidal emulsion contains a polystyrene block as a colloidalizing agent and a hydrocarbon as an emulsion.

膠體化劑係為了保持上述乳液之成分,並包含苯乙烯系彈性體。 The colloidalizing agent contains a styrene-based elastomer in order to retain the components of the above emulsion.

作為上述苯乙烯系彈性體,具有硬段以及軟段者較佳,且作為上述硬段,以聚苯乙烯嵌段較佳,且作為上述軟段,以聚烯烴嵌段較佳。 The styrene-based elastomer preferably has a hard segment and a soft segment, and is preferably a polystyrene block as the hard segment, and a polyolefin block as the soft segment.

上述聚苯乙烯嵌段中不僅包含苯乙烯之同元共聚物而成的嵌段(亦即聚苯乙烯嵌段),亦包含α-甲基苯乙烯之同元共聚物而成的嵌段(亦即聚α-甲基苯乙烯嵌段)、以及苯乙烯與α-甲基苯乙烯之共聚合物而成的嵌段。 The above polystyrene block includes not only a block of a homopolymer of styrene (that is, a polystyrene block) but also a block of a homopolymer of α-methylstyrene ( That is, a block of a poly-α-methylstyrene block and a copolymer of styrene and α-methylstyrene.

作為上述聚烯烴嵌段,有舉例如聚烯烴之同元共聚物而成之嵌段,例如聚乙烯嵌段、聚丙烯嵌段、聚丁烯嵌段、以及聚丁二烯嵌段、以及聚烯烴之共聚合物而成之嵌段、例如乙烯、丙烯、丁烯以及丁二烯等之共聚合物而成之嵌段。 As the above polyolefin block, there may be mentioned, for example, a block of a homopolymer of polyolefin, such as a polyethylene block, a polypropylene block, a polybutene block, and a polybutadiene block, and a poly A block formed of a copolymer of an olefin, for example, a copolymer of ethylene, propylene, butylene, and butadiene.

且,本說明書中,在方便上,丁二烯也作為正烯系單體使用。 Further, in the present specification, butadiene is also used as a normal olefin monomer.

且,上述軟段中亦包含聚丁二烯嵌段之氫加成物、以及丁二烯與乙烯、丙烯、丁烯及丁二烯等之共聚合物而成的嵌段之氫加成物。 Further, the soft segment further comprises a hydrogen adduct of a polybutadiene block and a hydrogen adduct of a block of butadiene and a copolymer of ethylene, propylene, butylene and butadiene. .

作為上述苯乙烯系彈性體,以在兩末端具有硬段,並在此等之間具有1種或複數種軟段較佳。 The styrene-based elastomer preferably has a hard segment at both ends, and one or a plurality of soft segments are preferably provided between the two.

作為上述苯乙烯系彈性體之具體例,有舉例如以下。 Specific examples of the styrene-based elastomer are as follows.

(i)聚苯乙烯-block-聚(乙烯-co-丙烯) (i) polystyrene-block-poly(ethylene-co-propylene)

(以下,有時省略成「SEP」) (The following may be omitted as "SEP")

(ii)聚苯乙烯-block-聚(乙烯-co-丙烯)-block-聚苯乙烯 (ii) polystyrene-block-poly(ethylene-co-propylene)-block-polystyrene

(以下,有時省略成「SEPS」) (The following may be omitted as "SEPS")

(iii)聚苯乙烯-block-聚(乙烯-co-丁烯)-block-聚苯乙烯 (iii) polystyrene-block-poly(ethylene-co-butylene)-block-polystyrene

(以下,有時省略成「SEBS」) (The following may be omitted as "SEBS")

(iv)聚苯乙烯-block-聚乙烯-block-聚(乙烯-co-丙烯)-block-聚苯乙烯 (iv) polystyrene-block-polyethylene-block-poly(ethylene-co-propylene)-block-polystyrene

(以下,有時省略成「SEEPS」) (The following may be omitted as "SEEPS")

上述苯乙烯系彈性體較佳為具有5,000~500,000,再較佳為具有10,000~400,000,且更較佳為具有50,000~300,000之重量平均分子量。若上述重量平均分子量低於5,000,則苯乙烯系彈性體會有難以保持在膠體構造之傾向,且若上述重量平均分子量超過500,000,則會有著用感降低之傾向。 The styrene-based elastomer preferably has a weight average molecular weight of 5,000 to 500,000, more preferably 10,000 to 400,000, and still more preferably 50,000 to 300,000. When the weight average molecular weight is less than 5,000, the styrene-based elastomer tends to be difficult to maintain in the colloidal structure, and if the weight average molecular weight exceeds 500,000, the feeling of use tends to decrease.

且,重量平均分子量之測定方法如後述。 Further, the method for measuring the weight average molecular weight will be described later.

上述苯乙烯系彈性體較佳為包含10~50質量%之聚苯乙烯嵌段與50~90質量%之聚烯烴嵌段,再較佳為包含15~40質量%之聚苯乙烯嵌段與60~85質量%之聚烯 烴嵌段,且更較佳為包含18~35質量%之聚苯乙烯嵌段與65~82質量%之聚烯烴嵌段。 The styrene-based elastomer preferably contains 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block, and more preferably 15 to 40% by mass of a polystyrene block. 60 to 85% by mass of polyolefin The hydrocarbon block, and more preferably contains 18 to 35% by mass of a polystyrene block and 65 to 82% by mass of a polyolefin block.

若聚苯乙烯嵌段的量低於10質量%,則會有聚苯乙烯嵌段難以形成後述微米層分離構造之傾向。若聚苯乙烯嵌段的量超過50質量%,則能夠保持乳液之聚烯烴嵌段的量變少,故能夠保持之乳液的量會有變少之傾向。且,聚苯乙烯嵌段之微米層分離構造的量變多,所形成的膠體乳液會凝固,會有著用感變差之傾向。 When the amount of the polystyrene block is less than 10% by mass, the polystyrene block tends to be difficult to form a micron-separated structure described later. When the amount of the polystyrene block exceeds 50% by mass, the amount of the polyolefin block capable of holding the emulsion is reduced, so that the amount of the emulsion that can be held tends to be small. Further, the amount of the micron layer separation structure of the polystyrene block is increased, and the formed colloidal emulsion is solidified, which tends to deteriorate the feeling of use.

上述苯乙烯系彈性體會生成膠體乳液之理由如以下所述。苯乙烯系彈性體之硬段會互相凝集形成一範圍,並有作為交聯點之作用。另一方面,軟段會發揮連結此等交聯點之網孔的角色。其結果,苯乙烯系彈性體具有作為彈性體之機能。 The reason why the above styrene-based elastomer forms a colloidal emulsion is as follows. The hard segments of the styrene elastomer will agglomerate to each other to form a range and function as a crosslinking point. On the other hand, the soft segment will play the role of the mesh connecting these cross-linking points. As a result, the styrene-based elastomer has a function as an elastomer.

將上述苯乙烯系彈性體與上述乳液,尤其是與烴混合後,苯乙烯系彈性體之軟段會保持上述乳液,另一方面,硬段會維持在形成一範圍之狀態。其結果,苯乙烯系彈性體與上述乳液之混合物(膠體乳液)具有下述彈性體之機能,該彈性體具有比苯乙烯系彈性體單體更低的壓縮應力。 When the styrene-based elastomer is mixed with the above emulsion, particularly with a hydrocarbon, the soft segment of the styrene-based elastomer retains the emulsion, and on the other hand, the hard segment is maintained in a state of being formed. As a result, the mixture of the styrene-based elastomer and the above emulsion (colloidal emulsion) has the function of an elastomer having a lower compressive stress than the styrene-based elastomer monomer.

且,上述乳液僅會被保持在苯乙烯系彈性體之軟段中較鬆的網孔,並能夠移動到膠體乳液的表面。 Moreover, the above emulsion is only retained in the looser mesh in the soft section of the styrenic elastomer and can be moved to the surface of the colloidal emulsion.

上述乳液包含烴。本說明書中,「烴」意指碳與氫而成之化合物。作為上述烴,有舉出鏈狀烴,例如石臘系烴(不包含雙鍵以及三鍵,亦稱作烷)、正烯系烴 (包含1個雙鍵,亦稱作烯)、乙炔系烴(包含1個三鍵,亦稱作炔)、及包含2個以上選自雙鍵以及三鍵所成群中之鍵結的烴、以及環狀烴,例如芳香族烴、脂環式烴。 The above emulsion contains a hydrocarbon. In the present specification, "hydrocarbon" means a compound in which carbon and hydrogen are formed. Examples of the hydrocarbon include a chain hydrocarbon such as a paraffinic hydrocarbon (excluding a double bond and a triple bond, also referred to as an alkane), and a normal olefinic hydrocarbon. (containing one double bond, also referred to as an alkene), an acetylene hydrocarbon (containing one triple bond, also referred to as an alkyne), and a hydrocarbon containing two or more bonds selected from the group consisting of a double bond and a triple bond And cyclic hydrocarbons such as aromatic hydrocarbons and alicyclic hydrocarbons.

作為上述烴,為鏈狀烴以及脂環式烴較佳,為鏈狀烴再較佳,為石臘系烴、正烯系烴、及包含2個以上之雙鍵的烴(不包含三鍵)更較佳,且為石臘系烴更較佳。 The hydrocarbon is preferably a chain hydrocarbon or an alicyclic hydrocarbon, and more preferably a chain hydrocarbon, and is a paraffinic hydrocarbon, a normal olefinic hydrocarbon, and a hydrocarbon containing two or more double bonds (excluding a triple bond) More preferably, it is more preferred as a paraffinic hydrocarbon.

上述鏈狀烴中包含直鏈狀烴以及分支狀烴。 The chain hydrocarbons include linear hydrocarbons and branched hydrocarbons.

上述烴為在40℃中具有0.01~80mm2/s之動力黏度較佳,具有0.01~4.0質量%之抱水率較佳,且具有未滿1,000之重量平均分子量較佳。是因為烴要作為後述之體液滑性賦予劑來作用。 The above hydrocarbon has a dynamic viscosity of preferably 0.01 to 80 mm 2 /s at 40 ° C, a water absorbing ratio of 0.01 to 4.0% by mass, and a weight average molecular weight of less than 1,000. This is because the hydrocarbon acts as a body fluid slip imparting agent to be described later.

本發明之膠體乳液中,乳液(例如烴)會有一定量滲出膠體乳液的表面。滲出表面的乳液會移動到著用者的肌膚,或者會與經血、尿等體液一起滑落等到吸收體內部而消失,之後新的乳液會從膠體乳液再滲出。因此,膠體乳液能夠連續地釋放出乳液。 In the colloidal emulsion of the present invention, an emulsion (e.g., a hydrocarbon) will have a certain amount of oozing out of the surface of the colloidal emulsion. The emulsion that oozes the surface will move to the user's skin, or it will slide down with the body fluids such as menstrual blood and urine until the inside of the absorber disappears, and then the new emulsion will ooze out from the colloidal emulsion. Therefore, the colloidal emulsion is capable of continuously releasing the emulsion.

上述乳液較佳為包含50~100質量%,再較佳為包含60~100質量%,且更較佳為包含70~100質量%之上述烴。這是因為以從膠體形成之觀點來看。 The above emulsion preferably contains 50 to 100% by mass, more preferably 60 to 100% by mass, and still more preferably 70 to 100% by mass of the above hydrocarbon. This is because from the viewpoint of formation of colloids.

上述膠體乳液中,作為上述乳液,除了上述烴以外,亦能夠進一步包含該發明所屬技術領域中熟知用來作為乳液之成分。 In the above colloidal emulsion, as the above-mentioned emulsion, in addition to the above hydrocarbons, it is possible to further comprise a component which is well known as an emulsion in the technical field of the invention.

上述膠體乳液中,作為上述乳液,除了上述烴以外,進一步包含體液滑性賦予劑較佳,該體液滑性賦予劑具有超過0.00且0.60以下之IOB、與40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 In the above-mentioned colloidal emulsion, it is preferable to further include a body fluid slip imparting agent as the above-mentioned emulsion, and the body fluid slip imparting agent has an IOB of more than 0.00 and 0.60 or less, and 0.01 to 80 mm 2 /s at 40 ° C. The dynamic viscosity, the water holding ratio of 0.01 to 4.0% by mass, and the weight average molecular weight of less than 1,000.

上述體液滑性賦予劑為本案申請人之申請案,與國際公開第2012/133724號說明書所記載之「血液改質劑」相同成分,且同樣地與國際公開第2013/129236號說明書所記載之「血液滑性賦予劑」為相同成分。 The above-mentioned body fluid slip imparting agent is the same as the "blood modifier" described in the specification of International Publication No. 2012/133724, and is similarly described in the specification of International Publication No. 2013/129236. The "slipperiness imparting agent" is the same component.

藉由上述膠體乳液中包含上述體液滑性賦予劑,體液滑性賦予劑會從膠體乳液連續地釋放出,經過長時間,能夠使到達液體透過性層之體液等迅速地滑落到吸收體的內部。 When the body fluid slip imparting agent is contained in the colloidal emulsion, the body fluid slip imparting agent is continuously released from the colloidal emulsion, and the body fluid or the like reaching the liquid permeable layer can be quickly slipped to the inside of the absorbent body over a long period of time. .

IOB(Inorganic Organic Balance)為表示親水性以及親油性之平衡的指標,本說明書中意指是根據小田等之下式:IOB=無機性值/有機性值所算出之值。 IOB (Inorganic Organic Balance) is an index indicating the balance between hydrophilicity and lipophilicity, and the present specification means a value calculated according to the formula of Oda et al.: IOB=inorganic value/organicity value.

上述無機性值與有機性值意指基於藤田穆「有機化合物之預測與有機概念圖」化學區域Vol.11,No.10(1957)p.719-725)所記載之有機概念圖。 The above inorganic value and organic value mean an organic concept map described in Fujita Mu's "Organic Compound Prediction and Organic Concept Map" Chemical Region Vol. 11, No. 10 (1957) p. 719-725).

藤田氏所述之主要的基之有機性值以及無機性值統整於下述表1。 The organic and inorganic values of the main bases described by Fujita are summarized in Table 1 below.

上述動力黏度是根據JIS K 2283:2000之「5.動力黏度試驗方法」,並使用Cannon-Fenske逆流形黏度計,在40℃之試驗溫度下測定。 The above dynamic viscosity is measured according to "5. Dynamic viscosity test method" of JIS K 2283:2000, and measured at a test temperature of 40 ° C using a Cannon-Fenske counter-flow viscosity meter.

本說明書中,上述「抱水率」意指會保持物質之水的比率,並由以下來進行測定。 In the present specification, the above-mentioned "water holding ratio" means the ratio of the water which retains the substance, and is measured by the following.

(1)在40℃之恆溫室中將試驗管、橡皮塞、應測定之物質以及去離子水靜置24小時。 (1) The test tube, the rubber stopper, the substance to be measured, and deionized water were allowed to stand in a thermostatic chamber at 40 ° C for 24 hours.

(2)在上述恆溫室中,於20mL的試驗管內放入應測定之物質5.0g與去離子水5.0g。 (2) In the above-mentioned constant temperature chamber, 5.0 g of the substance to be measured and 5.0 g of deionized water were placed in a test tube of 20 mL.

(3)在上述恆溫室中,以橡皮拴住試驗管口,迴轉1次,靜置5分鐘。 (3) In the above-mentioned constant temperature chamber, the test tube was clamped with a rubber, rotated once, and allowed to stand for 5 minutes.

(4)在上述恆溫室中,將3.0g應測定之物質的層(通常為上層),採取至直徑90mm之質量:W0(g)的玻璃製器皿上。 (4) In the above-mentioned constant temperature chamber, 3.0 g of the substance to be measured (usually the upper layer) was taken up to a glass vessel having a diameter of 90 mm and a mass of W 0 (g).

(5)將上述器皿於烤箱內以105℃加熱3小時,使水分蒸發,並測定每個器皿之質量:W1(g)。 (5) The above vessel was heated in an oven at 105 ° C for 3 hours to evaporate water, and the mass of each vessel was measured: W 1 (g).

(6)將抱水率根據以下之式算出。 (6) The water holding ratio is calculated according to the following formula.

抱水率(質量%)=100×[W0(g)-W1(g)]/3.0(g) Water holding capacity (% by mass) = 100 × [W 0 (g) - W 1 (g)] / 3.0 (g)

實施3次測定,並採用平均值。 Three measurements were performed and the average was used.

本說明書中,上述「重量平均分子量」包含多分散系之化合物(例如由先後聚合所製造之化合物、複數之脂肪酸與複數之脂肪族一元醇類所生成之酯)、與單一化合物(例如1種脂肪酸與1種脂肪族一元醇類所生成之酯)的概念,並且意指在Ni個分子量Mi的分子(i=1,或i=1,2…)而成之系統中,由下述式:Mw=ΣNiMi 2/ΣNiMi所求之MwIn the present specification, the above "weight average molecular weight" includes a polydisperse compound (for example, a compound produced by sequential polymerization, an ester of a plurality of fatty acids and a plurality of aliphatic monohydric alcohols), and a single compound (for example, one kind) the concept of generating a fatty acid with one of aliphatic monohydric alcohol esters), and N i mean a molecule of molecular weight M i (i = 1, or i = 1,2 ...) of the system formed by the following The formula: M w = Σ N i M i 2 / Σ N i M i is obtained by M w .

本說明書中,重量平均分子量意指由透膠層析術(GPC)所求之聚苯乙烯換算的值。 In the present specification, the weight average molecular weight means a polystyrene-converted value obtained by gel permeation chromatography (GPC).

作為GPC之測定條件,有舉例如以下。 The measurement conditions of GPC are as follows, for example.

機種:(股)日立High-Technologies製 高效能液相層析Lachrom Elite Model: (share) Hitachi High-Technologies system High performance liquid chromatography Lachrom Elite

管柱:昭和電工(股)製SHODEX KF-801、KF-803以及KF-804 Pipe column: SHODEX KF-801, KF-803 and KF-804 made by Showa Denko (share)

溶析液:THF Lysate: THF

流量:1.0mL/分 Flow rate: 1.0mL/min

打入量:100μL Driving amount: 100μL

檢測:RI(示差折射計) Detection: RI (differential refractometer)

上述體液滑性賦予劑較佳為下述(i)及(ii)、以及選自此等之任意組合所成之群,(i)具有(i-1)與(i-2)之化合物,(i-1)為烴基部分,(i-2)為被插入上述烴基部分的C-C單鍵之間,且選自羰基(-CO-)以及氧基(-O-)所成群中的一個或複數個相同或相異之基、及(ii)具有(ii-1)與(ii-2)與(ii-3)之化合物,(ii-1)為烴基部分,(ii-2)為被插入上述烴基部分的C-C單鍵之間,且選自羰基(-CO-)以及氧基(-O-)所成群中的一個或複數個相同或相異之基,(ii-3)為取代上述烴基部分的氫原子,且選自羧基(-COOH)以及氫氧基(-OH)所成群中的一個或複數個相同或相異之基。 The body fluid slip imparting agent is preferably a group of the following (i) and (ii), and any combination selected from the group consisting of (i) a compound having (i-1) and (i-2), (i-1) is a hydrocarbyl moiety, (i-2) is a group of CC single bonds inserted into the above hydrocarbyl moiety, and is selected from the group consisting of a carbonyl group (-CO-) and an oxy group (-O-). Or a plurality of identical or different groups, and (ii) a compound having (ii-1) and (ii-2) and (ii-3), (ii-1) being a hydrocarbon moiety, and (ii-2) being Inserted between the CC single bonds of the above hydrocarbyl moiety, and selected from one or a plurality of identical or dissimilar groups in the group of carbonyl (-CO-) and oxy (-O-), (ii-3) It is a hydrogen atom substituted for the above hydrocarbon moiety, and is selected from one or a plurality of identical or different groups in a group of a carboxyl group (-COOH) and a hydroxyl group (-OH).

且,上述烴基部分與上述烴基同義。 Further, the above hydrocarbon group is synonymous with the above hydrocarbon group.

上述(i)以及(ii)之化合物中,有插入2個以上的氧基(-O-)時,各氧基(-O-)不相鄰。因此,上述(i)以及(ii)之化合物中不包含連續氧基之化合物(所謂過氧化物)。 In the compounds of the above (i) and (ii), when two or more oxy groups (-O-) are inserted, each oxy group (-O-) is not adjacent. Therefore, the compound of the above (i) and (ii) does not contain a compound of a continuous oxy group (so-called peroxide).

上述體液滑性賦予劑再較佳為下述(i’)及(ii’)、以及選自此等之任意組合所成之群,(i’)具有(i’-1)與(i’-2)之化合物,(i’-1)為烴基部分,(i’-2)為被插入上述烴基部分的C-C單鍵之間,且選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO-)、以及醚鍵(-O-)所成群中的一個或複數個相同或相異之鍵結、及 (ii’)具有(ii’-1)與(ii’-2)與(ii’-3)之化合物,(ii’-1)為烴基部分,(ii’-2)為被插入上述烴基部分的C-C單鍵之間,且選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO-)、以及醚鍵(-O-)所成群中的一個或複數個相同或相異之鍵,(ii’-3)為取代上述烴基部分之氫原子,且選自羧基(-COOH)以及氫氧基(-OH)所成群中的一個或複數個相同或相異之基。 The body fluid slip imparting agent is further preferably the following (i') and (ii'), and a group selected from any combination of these, (i') having (i'-1) and (i' a compound of -2), (i'-1) is a hydrocarbyl moiety, (i'-2) is a CC single bond inserted into the above hydrocarbyl moiety, and is selected from a carbonyl bond (-CO-), an ester bond (- One or a plurality of identical or different bonds in a group of COO-), carbonate bonds (-OCOO-), and ether bonds (-O-), and (ii') a compound having (ii'-1) and (ii'-2) and (ii'-3), (ii'-1) being a hydrocarbon moiety, and (ii'-2) being inserted into the above hydrocarbon moiety Between the CC single bonds, and one selected from the group consisting of a carbonyl bond (-CO-), an ester bond (-COO-), a carbonate bond (-OCOO-), and an ether bond (-O-) a plurality of identical or distinct bonds, (ii'-3) being a hydrogen atom replacing the above hydrocarbyl moiety, and one or a plurality of the same selected from the group consisting of a carboxyl group (-COOH) and a hydroxyl group (-OH) Or the basis of difference.

且,上述烴基部分與上述烴基相同。 Further, the above hydrocarbon group is the same as the above hydrocarbon group.

上述(i’)以及(ii’)之化合物中,插入2以上相同或相異之鍵時,亦即插入選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO-)以及醚鍵(-O-)中之2個以上相同或相異之鍵時,各個鍵不相鄰,且各個鍵之間至少介隔1個碳原子。 In the above compounds (i') and (ii'), when two or more identical or different bonds are inserted, that is, a bond selected from a carbonyl bond (-CO-), an ester bond (-COO-), or a carbonate bond ( When -OCOO-) and two or more identical or different bonds in the ether bond (-O-), the respective bonds are not adjacent, and at least one carbon atom is interposed between the respective bonds.

作為上述體液滑性賦予劑,有舉出(a1)鏈狀烴基四元醇與至少1個脂肪酸之酯、(a2)鏈狀烴基三元醇與至少1個脂肪酸之酯、(a3)鏈狀烴基二元醇與至少1個脂肪酸之酯、(b1)鏈狀烴基四元醇與至少1個脂肪族一元醇類之醚、(b2)鏈狀烴基三元醇與至少1個脂肪族一元醇類之醚、(b3)鏈狀烴基二元醇與至少1個脂肪族一元醇類之醚、(c1)具有4個羧基的鏈狀烴基四羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯、(c2)具有3個羧基的鏈狀烴基三羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯、(c3)具有2個羧基的鏈狀烴基二羧酸、羥酸、烷氧酸或氧酸與至少1 個脂肪族一元醇類之酯、(d1)脂肪族一元醇類與脂肪族一元醇類之醚、(d2)二烷基酮、(d3)脂肪酸與脂肪族一元醇類之酯、(d4)二烷基碳酸酯、(e1)聚氧C3~C6烷二醇、(e2)聚氧C3~C6烷二醇與至少1個脂肪酸之酯、以及(e3)聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚、以及此等之任意組合。 Examples of the body fluid slip imparting agent include an ester of (a 1 ) a chain hydrocarbon tetrahydric alcohol and at least one fatty acid, and an ester of (a 2 ) a chain hydrocarbon triol and at least one fatty acid, (a 3 ) An ester of a chain hydrocarbyl glycol with at least one fatty acid, (b 1 ) a chain hydrocarbyl tetraol and at least one aliphatic monohydric alcohol, (b 2 ) a chain hydrocarbyl triol and at least 1 An aliphatic monohydric alcohol ether, (b 3 ) a chain hydrocarbyl diol and at least one aliphatic monohydric alcohol ether, (c 1 ) a chain hydrocarbyl tetracarboxylic acid having four carboxyl groups, a hydroxy acid, An ester of an alkoxylic acid or oxyacid with at least one aliphatic monohydric alcohol, (c 2 ) a chain hydrocarbyl tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid with at least one aliphatic mono An ester of an alcohol, (c 3 ) a chain hydrocarbyl dicarboxylic acid having two carboxyl groups, an ester of a hydroxy acid, an alkoxy acid or an oxyacid with at least one aliphatic monohydric alcohol, (d 1 ) an aliphatic monohydric alcohol Ethers of aliphatic and monohydric alcohols, (d 2 )dialkyl ketones, esters of (d 3 ) fatty acids and aliphatic monohydric alcohols, (d 4 )dialkyl carbonates, (e 1 )polyoxy C 3 ~ C 6 alkylene glycol, (e 2) polyoxy C 3 ~ C 6 alkyl At least one fatty alcohol and the ester, and (e 3) polyoxy C 3 ~ C 6 alkylene glycol and at least one of the aliphatic monohydric alcohol ethers, and any combination of these.

以下針對此等化合物進行說明。 These compounds are described below.

[(a1)鏈狀烴基四元醇與至少1個脂肪酸之酯] [(a 1 ) an ester of a chain hydrocarbon-based tetraol with at least one fatty acid]

鏈狀烴基四元醇意指上述鏈狀烴基的氫原子(合計4個)被氫氧基(-OH)(合計4個)所取代之化合物,作為上述鏈狀烴基四元醇與至少1個脂肪酸之酯,有舉例如下述式(1): 之季戊四醇與脂肪酸之四酯、下述式(2): 之季戊四醇與脂肪酸之三酯、下述式(3): 之季戊四醇與脂肪酸之二酯、下述式(4): 之季戊四醇與脂肪酸之單酯。(式中、R1~R4分別為鏈狀烴基) The chain hydrocarbon-based tetraol means a compound in which a hydrogen atom of the above-mentioned chain hydrocarbon group (four in total) is substituted by a hydroxyl group (-OH) (total of four) as the above-mentioned chain hydrocarbon-based tetraol and at least one An ester of a fatty acid, for example, the following formula (1): a tetraester of pentaerythritol and a fatty acid, and the following formula (2): a pentaerythritol and a fatty acid triester, the following formula (3): Diester of pentaerythritol and fatty acid, formula (4): a monoester of pentaerythritol and a fatty acid. (wherein, R 1 to R 4 are each a chain hydrocarbon group)

作為構成上述季戊四醇與脂肪酸之酯的脂肪酸(R1COOH、R2COOH、R3COOH以及R4COOH),有舉例如飽和脂肪酸,例如C2~C30之飽和脂肪酸,例如乙酸(C2)(C2表示碳數、相當於R1C、R2C,R3C或R4C之碳數,以下相同)、丙酸(C3)、丁酸(C4)以及其異構物,例如2-丙酸甲酯(C4)、戊酸(C5)以及其異構物,例如2-丁酸甲酯(C5)、2,2-二丙酸甲酯(C5)、己酸(C6)、庚酸(C7)、辛酸(C8)以及其異構物,例如2-己酸乙酯(C8)、壬酸(C9)、癸酸(C10)、十二酸(C12)、十四酸(C14)、十六酸(C16)、十七酸(C17)、十八酸(C18)、二十酸(C20)、二十二酸(C22)、二十四酸(C24)、二十六酸(C26)、二十八酸 (C28)、三十酸(C30)等、以及沒有被列舉的此等異構物。 As the fatty acid (R 1 COOH, R 2 COOH, R 3 COOH, and R 4 COOH) constituting the above ester of pentaerythritol and a fatty acid, for example, a saturated fatty acid such as a C 2 - C 30 saturated fatty acid such as acetic acid (C 2 ) may be mentioned. (C 2 represents a carbon number, a carbon number corresponding to R 1 C, R 2 C, R 3 C or R 4 C, the same applies hereinafter), propionic acid (C 3 ), butyric acid (C 4 ), and isomers thereof For example, methyl 2-propionate (C 4 ), valeric acid (C 5 ) and isomers thereof, such as methyl 2-butyrate (C 5 ), methyl 2,2-dipropionate (C 5 ) , hexanoic acid (C 6 ), heptanoic acid (C 7 ), octanoic acid (C 8 ) and isomers thereof, such as ethyl 2-hexanoate (C 8 ), citric acid (C 9 ), citric acid (C 10 ) ), dodecanoic acid (C 12 ), tetradecanoic acid (C 14 ), hexadecanoic acid (C 16 ), heptadecanoic acid (C 17 ), octadecanoic acid (C 18 ), eicosanoic acid (C 20 ), Twenty-two acid (C 22 ), tetracosic acid (C 24 ), hexacylic acid (C 26 ), octadecanoic acid (C 28 ), tridecanoic acid (C 30 ), etc., and not listed These isomers.

上述脂肪酸也能夠為不飽和脂肪酸。作為上述不飽和脂肪酸,有舉例如C3~C20之不飽和脂肪酸,例如單不飽和脂肪酸,例如巴豆酸(C4)、肉豆蔻油酸(C14)、棕櫚油酸(C16)、十八烯酸(C18)、反油酸(C18)、反11-十八烯酸(C18)、鱈油酸(C20)、二十烯酸(C20)等、二不飽和脂肪酸,例如亞油酸(C18)、二十碳二烯酸(C20)等、三不飽和脂肪酸,例如次亞麻油酸,例如α-次亞麻油酸(C18)以及γ-次亞麻油酸(C18)、松油酸(C18)、桐酸,例如α-桐酸(C18)以及β-桐酸(C18)、米德酸(C20)、二同-γ-次亞麻油酸(C20)、二十碳三烯酸(C20)等、四不飽和脂肪酸,例如十八碳四烯酸(C20)、花生四烯酸(C20)、花生油酸(C20)等、五不飽和脂肪酸,例如伯色五烯酸(bosseopentaenoic acid)(C18)、二十碳五烯酸(C20)等以及此等之部分氫加成物。 The above fatty acids can also be unsaturated fatty acids. Examples of the unsaturated fatty acid include C 3 to C 20 unsaturated fatty acids such as monounsaturated fatty acids such as crotonic acid (C 4 ), myristate oleic acid (C 14 ), palmitoleic acid (C 16 ), Octadecenoic acid (C 18 ), oleic acid (C 18 ), trans 11-octadecenoic acid (C 18 ), oleic acid (C 20 ), eicosenoic acid (C 20 ), etc., diunsaturated Fatty acids, such as linoleic acid (C 18 ), eicosadienoic acid (C 20 ), etc., triunsaturated fatty acids, such as linoleic acid, such as α -linolenic acid (C 18 ) and γ-sub-Asia Sesic acid (C 18 ), terpineic acid (C 18 ), tung acid, such as α -tungstic acid (C 18 ), β-tungstic acid (C 18 ), metic acid (C 20 ), di-γ-γ- Sublinoleic acid (C 20 ), eicosatrienoic acid (C 20 ), etc., tetraunsaturated fatty acids such as stearidonic acid (C 20 ), arachidonic acid (C 20 ), peanut oleic acid ( C 20 ) Iso-penta-unsaturated fatty acids, such as bosseopentaenoic acid (C 18 ), eicosapentaenoic acid (C 20 ), and the like, and some of the hydrogen adducts thereof.

[(a2)鏈狀烴基三元醇與至少1個脂肪酸之酯] [(a 2 ) an ester of a chain hydrocarbyl triol with at least one fatty acid]

鏈狀烴基三元醇意指上述鏈狀烴基的氫原子(合計3個)被氫氧基(-OH)(合計3個)所取代之化合物,作為上述鏈狀烴基三元醇與至少1個脂肪酸之酯,有舉例如下述式(5): 之丙三醇與脂肪酸之三酯、下述式(6): 之丙三醇與脂肪酸之二酯、以及下述式(7): (式中、R5~R7分別為鏈狀烴基)之丙三醇與脂肪酸之單酯。 The chain hydrocarbon-based triol means a compound in which a hydrogen atom (total of three) of the above-mentioned chain hydrocarbon group is substituted by a hydroxyl group (-OH) (total of three) as the above-mentioned chain hydrocarbon triol and at least one An ester of a fatty acid, for example, the following formula (5): The glycerol and fatty acid triester, the following formula (6): a diester of glycerol and a fatty acid, and the following formula (7): (wherein, R 5 to R 7 are each a chain hydrocarbon group) are monoesters of glycerin and a fatty acid.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(a3)鏈狀烴基二元醇與至少1個脂肪酸之酯] [(a 3 ) ester of a chain hydrocarbon-based diol with at least one fatty acid]

上述鏈狀烴基二元醇意指上述鏈狀烴基之氫原子(合計2個)被氫氧基(-OH)(合計2個)所取代之化合物,作為上述鏈狀烴基二元醇與至少1個脂肪酸之酯,有舉例如下述式(8): R8COOCkH2kOCOR9 (8)(式中,k為2~6之整數,且R8以及R9分別為鏈狀烴基)之C2~C6乙二醇與脂肪酸之二酯、以及下述式(9):R8COOCkH2kOH (9)(式中,k為2~6之整數,且R8為鏈狀烴基)之C2~C6乙二醇與脂肪酸之單酯。 The above-mentioned chain hydrocarbon-based glycol means a compound in which a hydrogen atom (two in total) of the above-mentioned chain hydrocarbon group is substituted by a hydroxyl group (-OH) (total of two) as the above-mentioned chain hydrocarbon-based glycol and at least 1 The ester of a fatty acid is, for example, the following formula (8): R 8 COOC k H 2k OCOR 9 (8) (wherein k is an integer of 2 to 6, and R 8 and R 9 are each a chain hydrocarbon group) C 2 ~ C 6 diester of ethylene glycol and fatty acid, and the following formula (9): R 8 COOC k H 2k OH (9) (wherein k is an integer of 2 to 6, and R 8 is a chain a monoester of a C 2 -C 6 ethylene glycol with a fatty acid.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(b1)鏈狀烴基四元醇與至少1個脂肪族一元醇類之醚] [(b 1 ) an ether of a chain hydrocarbyl tetraol and at least one aliphatic monohydric alcohol]

作為(b1)鏈狀烴基四元醇與至少1個脂肪族一元醇類之醚,有舉例如下述式(10)~(13): (式中、R10~R13分別為鏈狀烴基。)之季戊四醇與脂肪族一元醇類之四醚、三醚、二醚以及單醚。 Examples of the (b 1 ) chain hydrocarbyl tetrahydric alcohol and at least one aliphatic monohydric alcohol ether include the following formulas (10) to (13): (wherein, R 10 to R 13 are each a chain hydrocarbon group), and a tetraether, a triether, a diether, and a monoether of the pentaerythritol and the aliphatic monohydric alcohol.

且,鏈狀烴基四元醇如以上所述。 Further, the chain hydrocarbon-based tetrahydric alcohol is as described above.

作為上述脂肪族一元醇類,有舉例如飽和脂肪族一元醇類以及不飽和脂肪族一元醇類。 Examples of the aliphatic monohydric alcohols include saturated aliphatic monohydric alcohols and unsaturated aliphatic monohydric alcohols.

作為上述飽和脂肪族一元醇類,有舉例如C1~C20之飽和脂肪族一元醇類,例如甲醇(C1)(C1表示碳數,以下相同)、乙醇(C2)、丙醇(C3)以及其異構物,例如異丙醇(C3)、丁醇(C4)以及其異構物,例如sec-丁醇(C4)以及tert-丁醇(C4)、戊醇(C5)、己醇(C6)、庚醇(C7)、辛醇(C8)以及其異構物,例如2-乙基己醇(C8)、壬醇(C9)、癸醇(C10)、十二醇(C12)、十四醇(C14)、十六醇(C16)、十七醇(C17)、十八醇(C18)、以及二十醇(C20)、以及沒有被列舉的此等異構物。 Examples of the saturated aliphatic monohydric alcohols include, for example, C 1 to C 20 saturated aliphatic monohydric alcohols, for example, methanol (C 1 ) (C 1 represents a carbon number, the same applies hereinafter), ethanol (C 2 ), and propanol. (C 3 ) and its isomers, such as isopropanol (C 3 ), butanol (C 4 ), and isomers thereof, such as sec-butanol (C 4 ) and tert-butanol (C 4 ), Pentanol (C 5 ), hexanol (C 6 ), heptanol (C 7 ), octanol (C 8 ) and isomers thereof, such as 2-ethylhexanol (C 8 ), decyl alcohol (C 9 ), decyl alcohol (C 10 ), dodecyl alcohol (C 12 ), tetradecyl alcohol (C 14 ), cetyl alcohol (C 16 ), heptadecyl alcohol (C 17 ), stearyl alcohol (C 18 ), and Decanol (C 20 ), and such isomers not listed.

作為上述不飽和脂肪族一元醇類為將上述飽和脂肪族一元醇類的1個C-C單鍵以C=C雙鍵所取代者,有舉例如油醇。 The unsaturated aliphatic monohydric alcohol is one in which one C-C single bond of the above saturated aliphatic monohydric alcohol is substituted by a C=C double bond, and examples thereof include oleyl alcohol.

[(b2)鏈狀烴基三元醇與至少1個脂肪族一元醇類之醚] [(b 2 ) an ether of a chain hydrocarbon monohydric alcohol and at least one aliphatic monohydric alcohol]

作為(b2)鏈狀烴基三元醇與至少1個脂肪族一元醇類之醚,有舉例如下述式(14)~(16): (式中、R14~R16分別為鏈狀烴基。)之丙三醇與脂肪族一元醇類之三醚、二醚以及單醚。 Examples of the (b 2 ) chain hydrocarbon monohydric alcohol and at least one aliphatic monohydric alcohol ether include the following formulas (14) to (16): (wherein, R 14 to R 16 are each a chain hydrocarbon group, respectively), a triglyceride of an aliphatic monohydric alcohol, a diether, and a monoether.

且,鏈狀烴基三元醇以及脂肪族一元醇類如以上所述。 Further, the chain hydrocarbon monohydric alcohol and the aliphatic monohydric alcohol are as described above.

[(b3)鏈狀烴基二元醇與至少1個脂肪族一元醇類之醚] [(b 3 ) ether of a chain hydrocarbon-based diol and at least one aliphatic monohydric alcohol]

作為(b3)鏈狀烴基二元醇與至少1個脂肪族一元醇類之醚,有舉出下述式(17):R17OCnH2nOR18 (17)(式中,n為2~6之整數,且R17以及R18分別為鏈狀烴基)之C2~C6乙二醇與脂肪族一元醇類之二醚、以及下述式(18):R17OCnH2nOH (18) (式中,n為2~6之整數,且R17為鏈狀烴基)之C2~C6乙二醇與脂肪族一元醇類之單醚。 Examples of the (b 3 ) chain hydrocarbyl diol and at least one aliphatic monohydric alcohol ether include the following formula (17): R 17 OC n H 2n OR 18 (17) (wherein n is An integer of 2 to 6 and R 17 and R 18 are a chain hydrocarbon group, respectively, a diether of a C 2 -C 6 ethylene glycol and an aliphatic monohydric alcohol, and the following formula (18): R 17 OC n H 2n OH (18) (wherein, n is an integer of 2 to 6, and R 17 is a chain hydrocarbon group) of a monoether of C 2 -C 6 ethylene glycol and an aliphatic monohydric alcohol.

且,鏈狀烴基二元醇以及脂肪族一元醇類如以上所述。 Further, the chain hydrocarbon-based diol and the aliphatic monohydric alcohol are as described above.

[(c1)具有4個羧基的鏈狀烴基四羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯] [(c 1 ) an ester of a chain hydrocarbon tetracarboxylic acid, a hydroxy acid, an alkoxy acid or an oxyacid having 4 carboxyl groups and at least one aliphatic monohydric alcohol]

作為(c1)具有4個羧基的鏈狀烴基四羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯、二酯、三酯以及四酯。 (c 1 ) an ester of a chain hydrocarbon tetracarboxylic acid, a hydroxy acid, an alkoxy acid or an oxyacid having four carboxyl groups and at least one aliphatic monohydric alcohol, for example, a monoester, a diester or a triester thereof Tetraester.

[(c2)具有3個羧基的鏈狀烴基三羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯] [(c 2 ) an ester of a chain hydrocarbon group of a tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid with at least one aliphatic monohydric alcohol]

作為(c2)具有3個羧基的鏈狀烴基三羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯、二酯以及三酯。 The (c 2 ) ester of a chain hydrocarbon group of a tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid and at least one aliphatic monohydric alcohol may, for example, be a monoester, a diester or a triester.

[(c3)具有2個羧基的鏈狀烴基二羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯] [(c 3 ) an ester of a chain hydrocarbyl dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid with at least one aliphatic monohydric alcohol]

作為(c3)具有2個羧基的鏈狀烴基二羧酸、羥酸、烷氧酸或氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯以及二酯。 The ester of (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid with at least one aliphatic monohydric alcohol may, for example, be a monoester or a diester.

[(d1)脂肪族一元醇類與脂肪族一元醇類之醚] [(d 1 ) Ether of aliphatic monohydric alcohols and aliphatic monohydric alcohols]

脂肪族一元醇類如以上所述,作為上述脂肪族一元醇類與脂肪族一元醇類之醚,有舉出具有下述式(19):R19OR20 (19)(式中,R19以及R20分別為鏈狀烴基)之化合物。 The aliphatic monohydric alcohol is as described above, and as the ether of the above aliphatic monohydric alcohol and aliphatic monohydric alcohol, there is a formula (19): R 19 OR 20 (19) (wherein, R 19 And a compound wherein R 20 is a chain hydrocarbon group, respectively.

且,鏈狀烴基如以上所述。 Further, the chain hydrocarbon group is as described above.

[(d2)二烷基酮] [(d 2 )dialkyl ketone]

作為上述二烷基酮,有舉出具有下述式(20):R21COR22 (20)(式中,R21以及R22分別為烷基)之化合物。 The dialkyl ketone is a compound having the following formula (20): R 21 COR 22 (20) (wherein R 21 and R 22 are each an alkyl group).

[(d3)脂肪酸與脂肪族一元醇類之酯] [(d 3 ) ester of fatty acid with aliphatic monohydric alcohol]

脂肪酸以及脂肪族一元醇類如以上所述,作為上述脂肪酸與脂肪族一元醇類之酯,有舉例如具有下述式(21):R23COOR24 (21)(式中,R23以及R24分別為鏈狀烴基)之化合物。 The fatty acid and the aliphatic monohydric alcohol are as described above, and as the ester of the above fatty acid and the aliphatic monohydric alcohol, for example, it has the following formula (21): R 23 COOR 24 (21) (wherein R 23 and R 24 is a compound of a chain hydrocarbon group, respectively.

且,鏈狀烴基如以上所述。 Further, the chain hydrocarbon group is as described above.

[(d4)二烷基碳酸酯] [(d 4 )Dialkyl carbonate]

作為上述二烷基碳酸酯,有舉出具有下述式(22): R25OC(=O)OR26 (22)(式中,R25以及R26分別為烷基)之化合物。 The dialkyl carbonate is exemplified by the following formula (22): R 25 OC(=O)OR 26 (22) (wherein R 25 and R 26 are each an alkyl group).

[(e1)聚氧C3~C6烷二醇] [(e 1 ) polyoxy C 3 ~C 6 alkanediol]

上述聚氧C3~C6烷二醇意指i)具有氧基C3~C6伸烷基骨架,亦即具有選自氧基丙烯骨架、氧基丁烯骨架、氧基戊烯骨架以及氧基己烯骨架所成群中之任1種骨架,且在兩末端具有羥基之同元共聚物、ii)具有選自上述群中之2種以上的骨架,且在兩末端具有羥基之嵌段共聚合物、或iii)具有選自上述群中之2種以上的骨架,且在兩末端具有羥基之無規共聚物。 The above polyoxy C 3 -C 6 alkanediol means i) having an oxy C 3 -C 6 alkylene skeleton, that is, having an oxypropylene skeleton, an oxybutene skeleton, an oxypentene skeleton, and Any one of a skeleton in which a oxyhexene skeleton is grouped, and a homopolymer having a hydroxyl group at both terminals, ii) having two or more kinds of skeletons selected from the above group, and having a hydroxyl group at both ends A segment copolymer, or iii) a random copolymer having two or more skeletons selected from the above group and having a hydroxyl group at both terminals.

上述聚氧C3~C6烷二醇以下述式(23):HO-(CmH2mO)n-H (23)(式中,m為3~6之整數)所表示。 The polyoxy C 3 -C 6 alkanediol is represented by the following formula (23): HO-(C m H 2m O) n -H (23) (wherein m is an integer of 3 to 6).

[(e2)聚氧C3~C6烷二醇與至少1個脂肪酸之酯] [(e 2 ) an ester of polyoxy C 3 -C 6 alkanediol with at least one fatty acid]

作為上述聚氧C3~C6烷二醇與至少1個脂肪酸之酯,有舉出「(e1)聚氧C3~C6烷二醇」之項中所說明的聚氧C3~C6烷二醇之OH末端的一方或雙方經脂肪酸酯化者,亦即,單酯以及二酯。 Examples of the polyoxy C 3 ~ C 6 alkylene glycol and at least one ester of fatty acid, there are mentioned "(e 1) polyoxy C 3 ~ C 6 alkanediol" as described in Paragraph C 3 ~ polyoxy One or both of the OH ends of the C 6 alkanediol are esterified with a fatty acid, that is, a monoester and a diester.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(e3)聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚] [(e 3 ) an ether of a polyoxy C 3 -C 6 alkanediol and at least one aliphatic monohydric alcohol]

作為上述聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚,有舉出「(e1)聚氧C3~C6烷二醇」之項中所說明的聚氧C3~C6烷二醇之OH末端的一方或雙方經脂肪族一元醇類醚化者,亦即單醚以及二醚。 The polyoxy C 3 -C 6 alkanediol and at least one aliphatic monohydric alcohol are exemplified by the "(e 1 ) polyoxy C 3 -C 6 alkanediol". One or both of the OH ends of the oxygen C 3 -C 6 alkanediol are etherified with an aliphatic monohydric alcohol, that is, a monoether and a diether.

且,關於脂肪族一元醇類,有如以上所述。 Further, regarding the aliphatic monohydric alcohol, it is as described above.

體液滑性賦予劑之作用是如國際公開第2012/133724號說明書、國際公開第2013/129236號說明書等中所說明,但上述膠體乳液中包含作為乳液的體液滑性賦予劑時,能進一步得到以下之作用。 The action of the body fluid slip imparting agent is as described in the specification of International Publication No. 2012/133724 and the specification of International Publication No. 2013/129236. However, when the colloidal emulsion contains a body fluid slip imparting agent as an emulsion, it can be further obtained. The following effects.

上述膠體乳液會連續地釋放出體液滑性賦予劑至吸收性物品之肌膚接觸區域,例如,由於是緩緩釋放出,即使體液滑性賦予劑與體液一起滑落到吸收性物品內部,新的體液滑性賦予劑也會再從膠體乳液被供給至液體透過性層之表面,並使體液繼續滑落到吸收性物品內部。其結果,即使長時間連續使用吸收性物品時,液體透過性層也難以產生沾黏感,液體透過性層會繼續保持在乾爽狀態。 The above colloidal emulsion continuously releases the body fluid slip imparting agent to the skin contact area of the absorbent article, for example, because it is slowly released, even if the body fluid slip imparting agent slides down into the absorbent article together with the body fluid, the new body fluid The slip imparting agent is also supplied from the colloidal emulsion to the surface of the liquid permeable layer, and the body fluid continues to slide down into the interior of the absorbent article. As a result, even when the absorbent article is continuously used for a long period of time, the liquid permeable layer is less likely to have a sticky feeling, and the liquid permeable layer continues to be in a dry state.

上述乳液中較佳為包含0~50質量%,再較佳為包含0~40質量%,且更較佳為0~30質量%之上述體液滑性賦予劑。這是因為膠體形成之觀點。 The above emulsion preferably contains 0 to 50% by mass, more preferably 0 to 40% by mass, and still more preferably 0 to 30% by mass of the above-mentioned body fluid slip imparting agent. This is because of the idea of colloid formation.

上述膠體乳液中基於此等之合計100質量 份,較佳分別以1~30質量份以及70~99質量份,再較佳分別以2~20質量份以及80~98質量份,且更較佳分別以3~15質量份以及85~97質量份之比率包含膠體化劑與乳液。上述膠體化劑之比率若低於1質量份,則所形成之膠體乳液會難以具有彈性體之作用,或是當施加體壓時會有超過膠體乳液之彈性界限而變形的情況。上述膠體化劑之比率若超過30質量份,則所形成之膠體乳液的彈性會變高,有時著用感會變差。 100 masses based on the total of these colloidal emulsions Preferably, the amount is preferably from 1 to 30 parts by mass and from 70 to 99 parts by mass, more preferably from 2 to 20 parts by mass and from 80 to 98 parts by mass, and more preferably from 3 to 15 parts by mass and from 85 to 97 parts by weight. The ratio of parts by mass comprises a colloidizing agent and an emulsion. When the ratio of the above colloidizing agent is less than 1 part by mass, the formed colloidal emulsion may have difficulty in functioning as an elastomer or may be deformed when the body pressure is applied, which exceeds the elastic limit of the colloidal emulsion. When the ratio of the above colloidalizing agent exceeds 30 parts by mass, the elasticity of the formed colloidal emulsion becomes high, and the feeling of use may be deteriorated.

上述膠體乳液較佳為具有1~100kPa之50%變形時的壓縮應力,再較佳為具有1~80kPa之50%變形時的壓縮應力,且更較佳為具有1.5~60kPa之50%變形時的壓縮應力。 The colloidal emulsion preferably has a compressive stress at 50% deformation of 1 to 100 kPa, more preferably a compressive stress at 50% deformation of 1 to 80 kPa, and more preferably 50% deformation at 1.5 to 60 kPa. Compressive stress.

50%變形時的壓縮應力若低於1kPa,則施加體壓時會有膠體乳液超過彈性界限而變形,並有被破壞的情況,且50%變形時的壓縮應力若超過100kPa,則膠體乳液之彈性會變高,施加體壓時膠體乳液會難以變形,著用者會有察覺到違和感之情況。 When the compressive stress at 50% deformation is less than 1 kPa, when the body pressure is applied, the colloidal emulsion is deformed beyond the elastic limit and is broken, and if the compressive stress at 50% deformation exceeds 100 kPa, the colloidal emulsion is The elasticity will become high, and the colloidal emulsion will be difficult to deform when the body pressure is applied, and the user will perceive the feeling of discomfort.

以往的乳液塗覆、護膚劑等,為了將有效成分固定在特定的地方,採用將此等高黏度化(黏性體化)之手法。然而,將此等高黏度化之後,有效成分(柔軟劑等)會被鎖在乳液塗覆、護膚劑等之內部,變得難以發揮其機能。且,以往的乳液塗覆、護膚劑等,只是黏性體,若施加著壓等體壓,會有特定的地方無法固定,移動到吸收性物品內部,難以持續對著用者之肌膚作用的問題點。 Conventional emulsion coatings, skin care agents, and the like, in order to fix an active ingredient in a specific place, a method of making such a high viscosity (viscosity) is employed. However, after such high viscosity, the active ingredient (softener, etc.) is locked inside the emulsion coating, the skin care agent, etc., and it becomes difficult to exert its function. In addition, conventional emulsion coatings, skin care agents, and the like are only viscous bodies. If a body pressure such as pressure is applied, there is a certain place where it is not fixed, and it is moved inside the absorbent article, and it is difficult to continue to act on the skin of the user. Problems.

另一方面,上述膠體乳液會在有施加體壓等之範圍內表現作為彈性體之功能。因此,即使對上述膠體乳液施加較高的體壓,也不會一直停留在彈性變形,且不會被擠壓至頂部薄片的纖維等之間,而在體壓變低之後,彈性會回復,並回到原本的位置(肌膚接觸區域)。因此,膠體乳液中所包含之乳液能夠在所期望的位置中達成其作用。 On the other hand, the above colloidal emulsion exhibits the function as an elastomer in the range of application of body pressure or the like. Therefore, even if a high body pressure is applied to the above-mentioned colloidal emulsion, it does not stay at the elastic deformation all the time, and is not pressed between the fibers of the top sheet, etc., and after the body pressure becomes low, the elasticity regains, And return to the original position (skin contact area). Therefore, the emulsion contained in the colloidal emulsion can achieve its effect in the desired position.

本說明書中,膠體乳液之50%變形時的壓縮應力如以下所述來測定。 In the present specification, the compressive stress at the time of 50% deformation of the colloidal emulsion is measured as described below.

且,沒有特別規定之事項是根據JIS K 7181:2011「塑膠-壓縮特性之求出方法」之「3.7 x%變形時的壓縮應力」。 Further, the item which is not specified is the "compressive stress at 3.7 x% deformation" according to JIS K 7181:2011 "Method for Deriving Plastic-Compression Characteristics".

(1)在20℃ 65%RH之恆溫恆濕室中準備壓縮試驗機。 (1) A compression tester was prepared in a constant temperature and humidity chamber at 20 ° C and 65% RH.

且,本實施例中,作為壓縮試驗機,使用小型桌上型試驗機EzTest(島津製作所製)。 Further, in the present embodiment, a small table type tester EzTest (manufactured by Shimadzu Corporation) was used as the compression tester.

(2)在壓縮試驗機上裝置壓縮用模具。 (2) A mold for compression is mounted on a compression tester.

且,本實施例中,使用直徑120mm之不銹鋼製壓縮用模具。 Further, in the present embodiment, a stainless steel compression mold having a diameter of 120 mm was used.

(3)在壓縮用模具中裝置膠體乳液。 (3) A colloidal emulsion is placed in a mold for compression.

且,本實施例中,準備具有直徑為40mm且高度為8mm的圓筒形之膠體乳液。 Further, in the present embodiment, a cylindrical colloidal emulsion having a diameter of 40 mm and a height of 8 mm was prepared.

(4)以5mm/分之壓縮速度,將膠體乳液壓縮至壓縮量為4mm,亦即變形為50%為止,讀取壓縮力(N)。 (4) The colloidal emulsion was compressed at a compression speed of 5 mm/min. to a compression amount of 4 mm, that is, a deformation of 50%, and the compression force (N) was read.

(5)將壓縮力(N)換算成壓縮應力(Pa)。 (5) The compression force (N) is converted into a compressive stress (Pa).

且,壓縮應力是用相異的樣本實施,並採用3次測定值的平均值。 Moreover, the compressive stress was carried out with a different sample and the average of the three measured values was used.

[抗磨劑] [anti-wear agent]

上述膠體乳液除了膠體化劑以及乳液之外,能夠進一步包含抗磨劑。作為上述抗磨劑,有舉例如矽油、矽系樹脂、丙烯酸烷酯共聚合物、界面活性劑、長鏈脂肪族酯等。上述膠體乳液藉由包含抗磨劑,能夠期待在著用時,膠體乳液與著用者肌膚之間的摩擦變少,且著用者肌膚較不容易起疹之效果。 The above colloidal emulsion can further contain an anti-wear agent in addition to the colloidizing agent and the emulsion. Examples of the antiwear agent include eucalyptus oil, an anthracene resin, an alkyl acrylate copolymer, a surfactant, a long-chain aliphatic ester, and the like. By including an anti-wear agent, the colloidal emulsion can be expected to have less friction between the colloidal emulsion and the skin of the user when it is used, and the skin of the user is less likely to have a rash effect.

上述膠體乳液較佳為具有0.01~1.00,再較佳為具有0.02~0.50,且更較佳為具有0.03~0.03之靜磨擦係數。這是以著用者肌膚較難起疹之觀點來看。 The above colloidal emulsion preferably has a static friction coefficient of from 0.01 to 1.00, more preferably from 0.02 to 0.50, and still more preferably from 0.03 to 0.03. This is based on the point of view that the user's skin is more difficult to rash.

為了達成上述靜磨擦係數,膠體乳液中,相對於膠體乳液100質量份(膠體化劑以及乳液之合計100質量份),較佳以0.01~20質量份,再較佳以0.05~10質量份,且再較佳以0.1~7質量份之量包含上述抗磨劑。 In order to achieve the static friction coefficient, the colloidal emulsion is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 10 parts by mass, per 100 parts by mass of the colloidal emulsion (100 parts by mass of the colloidal agent and the emulsion). Further preferably, the above anti-wear agent is contained in an amount of 0.1 to 7 parts by mass.

上述靜磨擦係數如以下所述來測定。且,測定是在20℃×65%RH之恆溫恆濕室下進行。 The above static friction coefficient was measured as described below. Further, the measurement was carried out in a constant temperature and humidity chamber at 20 ° C × 65% RH.

(1)準備具有直徑為40mm且高度為8mm的圓筒形之膠體乳液。 (1) A cylindrical colloidal emulsion having a diameter of 40 mm and a height of 8 mm was prepared.

(2)作為靜磨擦試驗機,準備HEIDON摩擦測定機μs(MUSE)TYPE:94i(以下有時略稱為「MUSE」)。 (2) As a static friction tester, a HEIDON friction measuring machine μ s (MUSE) TYPE: 94i (hereinafter sometimes referred to as "MUSE") is prepared.

(3)MUSE之本體有裝置滑件。 (3) The body of MUSE has a device slider.

(4)打開MUSE之電源,確認顯示為“0.00”。 (4) Turn on the power of MUSE and confirm that the display is "0.00".

(5)在膠體乳液上裝上MUSE之滑件。 (5) Mount the MUSE slider on the colloidal emulsion.

(6)按下MUSE的測定鈕,讀取所顯示之值。 (6) Press the MUSE measurement button to read the displayed value.

(7)測定為在相異的膠體乳液中實施合計5次,並採用此等的平均值。 (7) The measurement was carried out 5 times in a different colloidal emulsion, and the average value of these was used.

上述膠體乳液在不損害本發明之效果的範圍內,能夠包含其他成分。 The above colloidal emulsion can contain other components within a range that does not impair the effects of the present invention.

作為上述其他成分,有舉例如抗氧化劑,例如BHT(2,6-二-t-丁基-p-甲酚)、BHA(丁基化甲氧苯酚)、沒食子酸丙酯等。 Examples of the other components include antioxidants such as BHT (2,6-di-t-butyl-p-cresol), BHA (butylated methoxyphenol), and propyl gallate.

作為上述其他成分,有舉例如維他命,例如天然維他命或合成維他命。作為上述維他命,有舉例如水溶性維他命,例如維他命B群,例如維他命B1、維他命B2、維他命B3、維他命B5、維他命B6、維他命B7、維他命B9、維他命B12等、維他命C。 As the other ingredients mentioned above, for example, vitamins such as natural vitamins or synthetic vitamins are mentioned. As the above vitamins, for example, water-soluble vitamins such as vitamin B group, such as vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 9 , vitamin B 12 , etc., vitamins C.

作為上述維他命,有舉例如脂溶性維他命,例如維他命A群、維他命D群、維他命E群以及維他命K群等。 As the above-mentioned vitamins, for example, fat-soluble vitamins such as a vitamin A group, a vitamin D group, a vitamin E group, and a vitamin K group are mentioned.

上述維他命中亦包含此等之衍生物。 These vitamins also contain such derivatives.

作為上述其他成分,有舉例如胺基酸,例如丙氨酸、天門冬醯胺、賴胺酸、組胺酸、脯氨酸、氫脯胺酸等以及胜肽。 As the above other components, for example, an amino acid such as alanine, aspartame, lysine, histidine, proline, hydroquinone, or the like, and a peptide are mentioned.

作為上述其他成分,例如沸石,例如天然沸石,例如方沸石、菱沸石、輝沸石、鈉沸石、束沸石以及 杆沸石(thomosonite)、以及合成沸石。 As the above other components, for example, zeolites such as natural zeolites such as analcime, chabazite, stilbite, sodium zeolite, zeolite, and Rodamosonite, and synthetic zeolite.

作為上述至少1種其他成分,有舉例如膽固醇、玻尿酸、卵磷脂、神經醯胺等。 Examples of the at least one other component include cholesterol, hyaluronic acid, lecithin, and neural amide.

且,作為上述其他成分,有舉例如藥劑,例如皮膚收斂劑、抗痘劑、抗皺劑、消皮下脂肪劑、美白劑、抗菌劑、抗霉劑等。 Further, examples of the other components include a drug such as a skin astringent, an anti-cree agent, an anti-wrinkle agent, a subcutaneous fat, a whitening agent, an antibacterial agent, and an antifungal agent.

作為上述皮膚收斂劑,有舉例如氧化鋅、硫酸鋁、單寧酸等、油溶性皮膚收斂劑,例如油溶性多酚。作為上述油溶性多酚,有舉出天然的油溶性多酚,例如黃柏樹皮萃取物、金絲桃屬萃取物、蕁麻萃取物、洋甘菊萃取物、牛蒡萃取物、鼠尾草萃取物、菩提樹萃取物、西洋菩提樹萃取物、樺樹萃取物、木賊萃取物、鼠尾草屬萃取物、鼠尾草萃取物、羌桃萃取物、木僅屬萃取物、枇杷葉萃取物、椴樹萃取物、啤酒花萃取物、甜栗萃取物、薏苡仁萃取物等。 Examples of the skin astringent agent include oil-soluble skin astringents such as zinc oxide, aluminum sulfate, and tannic acid, and oil-soluble polyphenols. Examples of the oil-soluble polyphenol include natural oil-soluble polyphenols such as cork bark extract, hypericum extract, castor extract, chamomile extract, burdock extract, sage extract, and linden extract. , linden extract, birch extract, squid extract, sage extract, sage extract, peony extract, wood extract, eucalyptus extract, eucalyptus extract, Hop extract, sweet chestnut extract, coix seed extract, etc.

作為上述抗痘劑,有舉例如水楊酸、過氧化苯甲醯、間苯二酚、硫、紅黴素、鋅等。 Examples of the anti-acne agent include salicylic acid, benzammonium peroxide, resorcinol, sulfur, erythromycin, zinc, and the like.

作為上述抗皺劑,有舉例如乳酸、水楊酸、水楊酸衍生物、乙二醇酸、植酸、硫辛酸、異磷脂酸。 Examples of the anti-wrinkle agent include lactic acid, salicylic acid, a salicylic acid derivative, glycolic acid, phytic acid, lipoic acid, and isophosphatidic acid.

作為上述消皮下脂肪劑,有舉例如黃呤嘌化合物,例如胺基非林、咖啡因、茶鹼、可可鹼等。 As the above-mentioned subcutaneous fat-reducing agent, for example, a xanthine compound such as aminylline, caffeine, theophylline, theobromine or the like can be mentioned.

作為上述美白劑,有舉例如菸酸、麴酸、熊果素、葡萄胺糖以及衍生物、植物固醇衍生物、抗壞血酸以及其衍生物、以及桑樹萃取物以及胎盤萃取物。 As the above whitening agent, for example, nicotinic acid, citric acid, arbutin, glucosamine and derivatives, phytosterol derivatives, ascorbic acid and derivatives thereof, and mulberry extract and placenta extract are mentioned.

且,作為上述其他成分,有舉例如消炎成分、pH調整劑、抗菌劑、保濕劑、香料,例如香味油、色素、染料、顏料、植物萃取物等。作為上述消炎成分,有舉例如來自天然的消炎劑,例如牡丹、黃苓、金絲桃屬、洋甘菊、甘草、桃花、洋艾草、紫蘇萃取物等、合成消炎劑,例如尿囊素、甘草酸二鉀等。 Further, examples of the other components include an anti-inflammatory component, a pH adjuster, an antibacterial agent, a moisturizer, and a fragrance such as a flavor oil, a coloring matter, a dye, a pigment, and a plant extract. As the anti-inflammatory component, for example, natural anti-inflammatory agents such as peony, scutellaria, hypericum, chamomile, licorice, peach, wormwood, perilla extract, etc., synthetic anti-inflammatory agents such as allantoin, licorice Dipotassium acid and the like.

作為上述pH調整劑,有舉出用來將皮膚保持在弱酸性者,例如蘋果酸、丁二酸、枸櫞酸、酒石酸、乳酸等。 As the pH adjuster, there are mentioned those used to keep the skin weakly acidic, such as malic acid, succinic acid, citric acid, tartaric acid, lactic acid and the like.

作為上述顏料,有舉例如氧化鈦。 As the above pigment, for example, titanium oxide is mentioned.

且,作為上述其他成分,有舉出具有護膚作用者,例如荷荷芭油、苦茶油以及鯊烷油。 Further, as the other components mentioned above, there are those having a skin care function, such as jojoba oil, bitter tea oil, and squalane oil.

且,作為上述其他成分,有舉出石油。 Further, as the other components mentioned above, petroleum is mentioned.

本發明之吸收性物品中,上述液體透過性層,在上述肌膚接觸區域中具有:具有上述膠體乳液之複數個膠體區域、與不具有膠體乳液之非膠體區域,且在上述肌膚不接觸區域中具有分別與上述複數個膠體區域以及上述非膠體區域在上述厚度方向重複之複數個膠體區域重複域以及非膠體區域重複域。 In the absorbent article of the present invention, the liquid permeable layer has a plurality of colloidal regions having the colloidal emulsion and a non-colloidal region having no colloidal emulsion in the skin contact region, and in the skin non-contact region And a plurality of colloidal region repeating domains and non-colloidal region repeating domains respectively repeating in the thickness direction with the plurality of colloidal regions and the non-colloidal regions.

圖1表示根據本發明實施形態的1個吸收性物品1之平面圖。圖1中所示之吸收性物品1,更具體來說生理用衛生棉中具有作為液體透過性層之頂部薄片2、與作為液體不透過性層之底部薄片(無圖示)、與在頂部薄片2以及底部薄片(無圖示)之間作為吸收性層之吸收體3。圖1中所示之吸收性物品1亦具有側邊薄片4與壓 印部5。圖1所示之吸收性物品1中,作為液體透過性之頂部薄片2在肌膚接觸區域7中具有:具有膠體乳液6的複數個膠體區域8與不具有膠體乳液的非膠體區域9。 Fig. 1 is a plan view showing an absorbent article 1 according to an embodiment of the present invention. The absorbent article 1 shown in Fig. 1, more specifically, the sanitary napkin has a top sheet 2 as a liquid permeable layer, a bottom sheet as a liquid impermeable layer (not shown), and a top portion. An absorbent body 3 serving as an absorbent layer between the sheet 2 and the bottom sheet (not shown). The absorbent article 1 shown in Fig. 1 also has a side sheet 4 and a pressure Printing section 5. In the absorbent article 1 shown in Fig. 1, the liquid-permeable top sheet 2 has, in the skin contact region 7, a plurality of colloidal regions 8 having a colloidal emulsion 6 and a non-colloidal region 9 having no colloidal emulsion.

圖1所示之吸收性物品1中,複數個線狀膠體乳液6會沿著吸收性物品1的縱向方向被連續地塗布。換而言之,頂部薄片2中具有互相平行且朝吸收性物品1的縱向方向連續延伸之複數個線狀膠體區域8。 In the absorbent article 1 shown in Fig. 1, a plurality of linear colloidal emulsions 6 are continuously applied along the longitudinal direction of the absorbent article 1. In other words, the top sheet 2 has a plurality of linear colloidal regions 8 which are parallel to each other and continuously extend in the longitudinal direction of the absorbent article 1.

圖2為圖1之區域A的II-II剖面之剖面圖,且為了說明,是一個僅表示頂部薄片2之圖。圖2中,頂部薄片2在肌膚接觸區域7中具有:具有膠體乳液6的複數個膠體區域8與不具有膠體乳液的非膠體區域9,且在肌膚不接觸區域10中具有分別與複數個膠體區域8以及非膠體區域9在厚度方向T重複的複數個膠體區域重複域11以及非膠體區域重複域12。 2 is a cross-sectional view taken along line II-II of the area A of FIG. 1, and for the sake of explanation, is a view showing only the top sheet 2. In Fig. 2, the top sheet 2 has in the skin contact region 7 a plurality of colloidal regions 8 having a colloidal emulsion 6 and a non-colloidal region 9 having no colloidal emulsion, and having a plurality of colloids in the skin non-contacting region 10, respectively. The region 8 and the non-colloidal region 9 repeat the domain 11 and the non-colloidal region repeating domain 12 in a plurality of colloidal region repeats in the thickness direction T.

圖2中,在互相相鄰的2個膠體區域8’以及8”中,互相相鄰的2個膠體區域8’以及8”之互相最近的點之2個鄰接點13’以及13”、與在該2個鄰接點13’以及13”的中間且存在非膠體區域9’之中間點14’、與2個鄰接點13’以及13”之在厚度方向T重複且分別存在膠體區域重複域11’以及11”的2個鄰接點相當點15’以及15”、與中間點14’之在厚度方向T重複且存在於非膠體區域重複域12’之中間點相當點16’具有i)~iii)之關係:i)2個鄰接點13’以及13”之水接觸角雙方都在85°以上、 ii)中間點14’中的水接觸角比2個鄰接點相當點15’以及15”中的水接觸角大、以及iii)中間點14’之水接觸角與中間點相當點16’中的水接觸角之差比-3(°)大。 In Fig. 2, in the two colloidal regions 8' and 8" adjacent to each other, two adjacent points 13' and 13" of the two closest colloidal regions 8' and 8" adjacent to each other, and In the middle of the two adjacent points 13' and 13" and the intermediate point 14' of the non-colloidal region 9', and the two adjacent points 13' and 13" are repeated in the thickness direction T and there is a colloidal region repeating domain 11 respectively. The two adjacent points of 'and 11' correspond to points 15' and 15", and the intermediate point 14' is repeated in the thickness direction T and exists in the middle point of the non-colloidal region repeating field 12'. The point 16' has i)~iii Relationship: i) Both water contact angles of the two adjacent points 13' and 13" are above 85°, Ii) the water contact angle in the intermediate point 14' is greater than the water contact angle in the point 15' and 15" of the two adjacent points, and iii) the water contact angle of the intermediate point 14' is in the point 16' of the intermediate point The difference in water contact angle is larger than -3 (°).

藉由2個鄰接點13’以及13”之水接觸角雙方都在85°以上,會使體液難以殘留在頂部薄片2上。 Since both of the water contact angles of the two adjacent points 13' and 13" are 85 or more, it is difficult for the body fluid to remain on the top sheet 2.

且,藉由中間點14中之水接觸角比2個鄰接點相當點15’以及15”中之水接觸角大、與中間點14之水接觸角之與中間點相當點16中之水接觸角的差比-3(°)大,自肌膚不接觸區域10延伸至肌膚接觸區域7,水接觸角會慢慢地變大,亦即,由於疏水性會慢慢地變高,一但被吸收到吸收體的體液較難以透過頂部薄片2而到達其肌膚接觸區域7。亦即,再濕性優異。 Moreover, the water contact angle in the intermediate point 14 is greater than the water contact angle in the corresponding points 15' and 15" of the two adjacent points, and the water contact angle with the intermediate point 14 is in contact with the water in the intermediate point corresponding point 16. The difference in angle is larger than -3 (°). From the non-contact area 10 of the skin to the skin contact area 7, the water contact angle will gradually become larger, that is, the hydrophobicity will gradually become higher, once It is difficult for the body fluid absorbed into the absorbent body to pass through the top sheet 2 to reach the skin contact region 7. That is, the rewet is excellent.

本發明之吸收性物品中,i)2個鄰接點之水接觸角雙方都在85°以上,且較佳為雙方都在90°以上,且更較佳為雙方都在100°以上。2個鄰接點之水接觸角較佳為150°以下,且再較佳為140°以下。這是以在保持體液之液體透過性層的透過性之同時,也能提高再濕性之觀點來看。 In the absorbent article of the present invention, i) the water contact angles of the two adjacent points are both 85 or more, and preferably both are 90 or more, and more preferably both are 100 or more. The water contact angle of the two adjacent points is preferably 150 or less, and more preferably 140 or less. This is because the permeability of the liquid permeable layer of the body fluid can be maintained and the rewet can be improved.

且,本發明之吸收性物品中,ii)中間點中之水接觸角比2個鄰接點相當點中之水接觸角大,較佳為大5°以上,且再較佳為大10°以上。中間點中之水接觸角比2個鄰接點相當點中之水接觸角大50°以下之範圍較佳,且大30°以下之範圍再較佳。這是以保持體液之液體透過 性層的透過性之同時,也增加液體透過性層之疏水性的梯度,並提高再濕性之觀點來看。 Further, in the absorbent article of the present invention, ii) the water contact angle in the intermediate point is larger than the water contact angle in the point corresponding to the two adjacent points, preferably 5° or more, and more preferably 10° or more. . The water contact angle in the intermediate point is preferably 50° or less larger than the water contact angle in the point corresponding to the two adjacent points, and the range of 30° or less is more preferable. This is to keep the liquid of the body fluid through The permeability of the layer also increases the gradient of the hydrophobicity of the liquid permeable layer and improves the rewet.

進而,本發明之吸收性物品中,iii)中間點之水接觸角與中間點相當點中之水接觸角的差較-3°大,較佳比-1°以上大,再較佳為比3°以上大。中間點之水接觸角與中間點相當點中之水接觸角的差較佳為30°以下,且再較佳為10°以下。這是以體液之吸收速度、與體液難以殘留在液體透過性層之觀點來看。 Further, in the absorbent article of the present invention, iii) the difference between the water contact angle of the intermediate point and the water contact angle in the point corresponding to the intermediate point is larger than -3°, preferably larger than -1°, and more preferably Larger than 3°. The difference in water contact angle between the water contact angle at the intermediate point and the intermediate point is preferably 30 or less, and more preferably 10 or less. This is based on the absorption rate of the body fluid and the fact that it is difficult for the body fluid to remain in the liquid permeable layer.

本發明之吸收性物品中,複數個膠體區域中,互相相鄰的2個膠體區域之至少一部份具有上述i)~iii)之關係,互相相鄰的2個膠體區域之組合較佳為20%以上,再較佳為40%以上,且更較佳為60%以上具有上述i)~iii)之關係。這是以本發明效果之觀點來看。 In the absorbent article of the present invention, in the plurality of colloidal regions, at least a portion of the two adjacent colloidal regions have the relationship of i) to iii), and the combination of the two colloidal regions adjacent to each other is preferably 20% or more, more preferably 40% or more, and still more preferably 60% or more has the relationship of the above i) to iii). This is in view of the effects of the present invention.

本發明之吸收性物品中,在接觸排泄口區域中具有上述i)~iii)之關係較佳。這是以本發明之效果的觀點來看。 In the absorbent article of the present invention, it is preferable to have the above relationship i) to iii) in the contact excretion opening region. This is from the viewpoint of the effects of the present invention.

圖3為用來說明本發明效果之模式圖。圖3相當於圖1之區域A的II-II剖面之剖面圖。如圖3所示,從膠體乳液6滲出的乳液17會隨著時間自膠體乳液6往平面方向P以及厚度方向T擴散,隨著膠體乳液6之基重、配置等關係,2個鄰接點13、中間點14、鄰接點相當點15以及中間點相當點16之水接觸角會滿足上述要件,而具有本發明之效果。 Fig. 3 is a schematic view for explaining the effects of the present invention. Figure 3 is a cross-sectional view taken along line II-II of the area A of Figure 1. As shown in FIG. 3, the emulsion 17 exuded from the colloidal emulsion 6 diffuses from the colloidal emulsion 6 in the plane direction P and the thickness direction T with time, and the two adjacent points 13 are related to the basis weight and arrangement of the colloidal emulsion 6. The water contact angle of the intermediate point 14, the adjacent point corresponding point 15 and the intermediate point corresponding point 16 satisfy the above requirements, and has the effect of the present invention.

本說明書中,水接觸角如以下來測定。 In the present specification, the water contact angle is measured as follows.

(1)在20℃之恆溫室中,準備協和界面科學製之接觸角計。 (1) Prepare a contact angle meter made by the Concord Interface Scientific in a thermostatic chamber at 20 °C.

(2)將應測定之試料靜置於上述恆溫室中24小時。 (2) The sample to be measured was allowed to stand in the above-mentioned constant temperature room for 24 hours.

(3)在應測定之試料的應測定之處滴下5刻度分之水滴(蒸餾水)。 (3) Drop 5 drops (distilled water) at the point where the sample to be measured should be measured.

(4)滴下5秒之後測定水接觸角。 (4) The water contact angle was measured after dropping for 5 seconds.

(5)將相異試料在相同之處合計進行10次測定,採用其平均值。 (5) The samples were counted 10 times in the same manner, and the average value was used.

圖1所示之實施形態中,複數個膠體區域8(膠體乳液6)會互相平行,且往吸收性物品1的縱向方向延伸,故2個鄰接點與其中間點所連接之直線會形成膠體區域8之垂直線。且,2個鄰接點相當點與中間點相當點所連接之直線也會形成膠體區域8之垂直線。 In the embodiment shown in Fig. 1, a plurality of colloidal regions 8 (colloidal emulsions 6) are parallel to each other and extend in the longitudinal direction of the absorbent article 1, so that the straight lines connecting the two adjacent points with the intermediate points form a colloidal region. 8 vertical lines. Moreover, the straight line connecting the two adjacent points and the point corresponding to the intermediate point also forms a vertical line of the colloidal region 8.

圖4表示根據有別於本發明實施形態之吸收性物品1的平面圖。圖4所示之吸收性物品1,更具體來說為生理用衛生棉中,頂部薄片2在其肌膚接觸區域7中包含膠體乳液6,且複數個點狀膠體乳液6被塗布成千鳥狀。換而言之,頂部薄片2中包含被配置成千鳥狀的複數個點狀膠體乳液6。 Fig. 4 is a plan view showing an absorbent article 1 according to an embodiment of the present invention. In the absorbent article 1 shown in Fig. 4, more specifically, in a sanitary napkin, the top sheet 2 contains a colloidal emulsion 6 in its skin contact region 7, and a plurality of point-like colloidal emulsions 6 are coated in a thousand birds. In other words, the top sheet 2 contains a plurality of point-like colloidal emulsions 6 arranged in a thousand bird shape.

圖5為圖4之區域A的擴大圖。圖5中表示在互相相鄰的2個膠體區域8’以及8”中,互相最近的點之2個鄰接點13’以及13”、與此等之中間點14’、與2個鄰接點13’以及13”在厚度方向重複且存在於膠體區域重複域(無圖示)中的2個鄰接點相當點15’以及15”、與 中間點14’之在厚度方向重複且存在於非膠體區域重複域(無圖示)之中間點相當點16’。 Fig. 5 is an enlarged view of a region A of Fig. 4. In Fig. 5, two adjacent points 13' and 13", the intermediate point 14', and two adjacent points 13 of the points closest to each other in the two adjacent colloidal regions 8' and 8" are shown. 'and 13' are repeated in the thickness direction and exist in the colloidal region repeating domain (not shown) at two adjacent points corresponding to points 15' and 15", and The intermediate point 14' is repeated in the thickness direction and exists at the intermediate point of the non-colloidal region repeating region (not shown) corresponding to the point 16'.

圖6表示根據有別於本發明之實施形態的吸收性物品1之平面圖,是相當於圖4之區域A的平面圖。圖6所示之吸收性物品1在頂部薄片2之肌膚接觸區域7中包含膠體乳液6,且複數個線狀膠體乳液6被延著吸收性物品1之縱向方向間隔地來塗布。換而言之,頂部薄片2中包含互相平行且往吸收性物品1之縱向方向間隔地延伸之複數個線狀膠體乳液6。 Fig. 6 is a plan view showing an absorbent article 1 according to an embodiment of the present invention, which corresponds to a region A of Fig. 4. The absorbent article 1 shown in Fig. 6 contains a colloidal emulsion 6 in the skin contact region 7 of the top sheet 2, and a plurality of linear colloidal emulsions 6 are applied at intervals in the longitudinal direction of the absorbent article 1. In other words, the top sheet 2 contains a plurality of linear colloidal emulsions 6 which are parallel to each other and which extend in the longitudinal direction of the absorbent article 1 at intervals.

圖6中也有表示在互相相鄰的2個膠體區域8’以及8”中,互相最近的點之2個鄰接點13’以及13”、與此等之中間點14’、與2個鄰接點13’以及13”之在厚度方向重複且存在於膠體區域重複域(無圖示)中的2個鄰接點相當點15’以及15”、與中間點14’之在厚度方向重複且存在於非膠體區域重複域(無圖示)之中間點相當點16’。 Also shown in Fig. 6 are two adjacent points 13' and 13" of the two closest colloidal regions 8' and 8" adjacent to each other, and intermediate points 14' and 2 adjacent points. The two adjacent points of 13' and 13" which are repeated in the thickness direction and exist in the colloidal region repeating region (not shown) are equivalent to points 15' and 15", and overlap with the intermediate point 14' in the thickness direction and exist in the non- The intermediate point of the colloidal region repeating domain (not shown) is equivalent to 16'.

本發明之吸收性物品中,具有膠體乳液之膠體區域的配置為滿足上述i)~iii)之關係,並無特別限制,例如,膠體區域在液體透過性層之肌膚接觸區域中被配置成線狀或點狀。 In the absorbent article of the present invention, the colloidal region having the colloidal emulsion is disposed so as to satisfy the relationship of the above i) to iii), and is not particularly limited. For example, the colloidal region is configured as a line in the skin contact region of the liquid permeable layer. Shape or point.

上述膠體區域中,液體透過性層在吸收性層與吸收性物品之厚度方向重複之範圍中,液體透過性層之面積較佳為占有1~50%,再較佳為占有3~40%,且更較佳為占有5~30%之區域。 In the above colloidal region, in the range in which the liquid permeable layer is repeated in the thickness direction of the absorbent layer and the absorbent article, the area of the liquid permeable layer preferably accounts for 1 to 50%, and more preferably 3 to 40%. More preferably, it occupies 5 to 30% of the area.

上述膠體區域中液體透過性層的面積若占有未滿1%,則會有難以發揮本發明效果之傾向。上述膠體區域中液體透過性層之面積若占有超過50%,則膠體區域不會吸收體液,故作為結果,吸收體液的區域會變得狹窄,會有吸收性物品之吸收性降低之傾向。 If the area of the liquid permeable layer in the above-mentioned colloidal region is less than 1%, the effect of the present invention tends to be difficult to exhibit. When the area of the liquid permeable layer in the colloidal region is more than 50%, the colloidal region does not absorb the body fluid, and as a result, the region in which the body fluid is absorbed becomes narrow, and the absorbability of the absorbent article tends to decrease.

且,為了達成上述塗布區域,液體透過性層在吸收性層與吸收性物品在厚度方向重複之範圍中,較佳以1~30g/m2,再較佳以2~20g/m2,且更較佳以3~10g/m2之基重包含上述膠體乳液。 Further, in order to achieve the coating region, the liquid permeable layer is preferably in the range of 1 to 30 g/m 2 , more preferably 2 to 20 g/m 2 , in the range in which the absorbent layer and the absorbent article are repeated in the thickness direction. More preferably, the above colloidal emulsion is contained at a basis weight of 3 to 10 g/m 2 .

本說明書中,膠體乳液之基重如以下來測定。 In the present specification, the basis weight of the colloidal emulsion is measured as follows.

(1)將頂部薄片之應測定的範圍以銳利的刀具,例如刀片的替換片切出,得到樣品。 (1) The range to be measured of the top sheet is cut out with a sharp cutter such as a replacement piece of the blade to obtain a sample.

(2)樣品之面積:測定S(m2)以及質量:M0(g)。 (2) Area of sample: Determination of S (m 2 ) and mass: M 0 (g).

(3)將樣品在膠體乳液為可溶之溶媒,例如芳香族系溶媒,例如二甲苯等之中,至少攪拌3分鐘,使膠體乳液溶解於溶媒中。 (3) The sample is stirred at least for 3 minutes in a solvent in which the colloidal emulsion is soluble, for example, an aromatic solvent such as xylene, and the colloidal emulsion is dissolved in the solvent.

(4)將樣品在測定質量的濾紙上進行過濾,在濾紙上,以溶媒將樣品充分洗淨。將濾紙上之樣品於100℃之烘箱內進行乾燥。 (4) The sample was filtered on a filter paper of a measured mass, and the sample was thoroughly washed with a solvent on a filter paper. The sample on the filter paper was dried in an oven at 100 °C.

(5)測定濾紙以及樣品之質量,藉由由此減去濾紙的質量,算出乾燥後之樣品質量:M1(g)。 (5) The mass of the filter paper and the sample were measured, and the mass of the dried sample was calculated by subtracting the mass of the filter paper: M 1 (g).

(6)將膠體乳液之基重GBW(g/m2)由下述式: GBW(g/m2)=[M0(g)-M1(g)]/S(m2)算出。 (6) The basis weight G BW (g/m 2 ) of the colloidal emulsion is given by the following formula: G BW (g/m 2 ) = [M 0 (g) - M 1 (g)] / S (m 2 ) Calculated.

且,為了減少誤差,自複數吸收性物品中採取複數樣品使樣品之總面積超過100cm2,重複複數次實驗,採用其平均值。 Further, in order to reduce the error, a plurality of samples were taken from the complex absorbent article so that the total area of the sample exceeded 100 cm 2 , and the experiment was repeated for a plurality of experiments, and the average value thereof was used.

本發明之吸收性物品中,液體透過性層為不織布或織布時,該不織布或織布以親水化處理過較佳。作為上述親水化處理,有舉出在不織布或織布纖維的表面上塗覆親水劑、對不織布或織布的原料之合成樹脂中混合親水劑等。在液體透過性層上稀疏地供存來自烴、體液滑性賦予劑等之親油性區域、與來自親水劑之親水性區域,這是因為更能發揮滑落性能,並使體液容易迅速地移動至吸收體。 In the absorbent article of the present invention, when the liquid permeable layer is a nonwoven fabric or a woven fabric, the nonwoven fabric or woven fabric is preferably hydrophilized. Examples of the hydrophilization treatment include a hydrophilic agent added to a surface of a nonwoven fabric or a woven fabric, and a hydrophilic agent or the like is added to a synthetic resin of a raw material of a nonwoven fabric or a woven fabric. The lipophilic region derived from a hydrocarbon, a body fluid slip imparting agent or the like and the hydrophilic region derived from the hydrophilic agent are sparsely supplied to the liquid permeable layer because the sliding property is more exhibited and the body fluid is easily moved to the body fluid easily Absorber.

上述膠體乳液能夠無特別限制地製造。 The above colloidal emulsion can be produced without particular limitation.

例如藉由在加熱後的乳液中添加膠體化劑後再混合而製造塗布液,且藉由將該塗布液塗布在應塗布膠體乳液的吸收性物品之液體透過性層上,能夠製造吸收性物品。 For example, a coating liquid can be produced by adding a colloidizing agent to the heated emulsion, followed by mixing, and the coating liquid can be applied to the liquid permeable layer of the absorbent article to which the colloidal emulsion is applied, thereby producing an absorbent article. .

上述膠體乳液能夠依照所期望,能夠作為包含揮發性溶媒,例如包含醇系溶媒、酯系溶媒、芳香族系溶媒等之塗布液來塗裝。上述塗布液藉由包含揮發性溶媒,由於上述塗布液之黏度會下降,能夠達到塗布容易且不需要塗裝時之加溫等塗布步驟的簡易化。 The colloidal emulsion can be applied as a coating liquid containing a volatile solvent, for example, an alcohol-based solvent, an ester-based solvent, or an aromatic solvent, as desired. When the coating liquid contains a volatile solvent, the viscosity of the coating liquid is lowered, and the coating step can be easily performed, and the coating step such as heating at the time of coating is not required to be simplified.

上述塗布液之塗布方法並無特別限制,能夠因應必要將塗布液加熱,再以例如非接觸式塗布機或接觸 式塗布機等進行塗布。 The coating method of the coating liquid is not particularly limited, and the coating liquid can be heated as necessary, and then, for example, a non-contact coater or contact. Coating is performed by a coater or the like.

作為上述非接觸式之塗布機,有舉例如螺旋式塗布機、淋幕式塗布機、噴霧式塗布機、浸漬式塗布機等,且作為接觸式之塗布機,有舉例如開槽式塗布機、圖形式塗布機等。 Examples of the non-contact type coater include a spiral coater, a curtain coater, a spray coater, and a dipping coater. Examples of the contact coater include a slot coater. , graphic coater, etc.

上述塗布液能夠在製造液體透過性層之素材,例如不織布時被塗布,或是在製造吸收性物品的生產線中,塗布於應塗布膠體乳液之吸收性物品上。以抑制設備投資的觀點來看,在吸收性物品的生產線中,塗布上述塗布液較佳,進而,為了抑制膠體乳液脫落而污染產線,在生產線的下游步驟,具體來說為將製品密封至個包裝之前,塗布上述塗布液較佳。 The coating liquid can be applied to a material for producing a liquid permeable layer, for example, when it is not woven, or can be applied to an absorbent article to which a colloidal emulsion is applied in a production line for producing an absorbent article. From the viewpoint of suppressing equipment investment, it is preferable to apply the above coating liquid in the production line of the absorbent article, and further, to suppress the colloidal emulsion from falling off and contaminating the production line, in the downstream step of the production line, specifically, sealing the product to It is preferred to apply the above coating liquid before packaging.

作為本發明之吸收性物品,有舉例如拋棄式尿布、失禁墊片、生理用衛生棉、護墊。 Examples of the absorbent article of the present invention include disposable diapers, incontinence pads, sanitary napkins, and pads.

[實施例] [Examples]

以下,舉例說明本發明,但本發明並不限定於此等之例。 Hereinafter, the present invention will be described by way of examples, but the present invention is not limited thereto.

[例1] [example 1]

將SEPS(苯乙烯含量:20質量%,重量平均分子量:約26萬)(以下有時稱作「SEPS-1」)2份與SEBS(苯乙烯含量:31質量%,重量平均分子量:約16萬)(以下有時稱作「SEBS-2」)5份添加至加熱至約140℃ 之PARLEAM 6(日油股份公司製,藉由共聚合流動異烷烴、異丁烯以及n-丁烯,接著加成氫所生成之分支狀烴,聚合度:約5~約10,重量平均分子量:約330)90份與矽油(Dow Corning Toray股份公司製,SH200-100cs,二甲基聚矽氧烷,25℃下之動力黏度為100mm2/s)3份之混合物中,藉由將此等一邊攪拌5小時,一邊進行混合,生成混合物,如圖1所示,塗布在吸收性物品之頂部薄片的肌膚接觸區域上,得到吸收性物品No.1-1。吸收性物品No.1-1中,膠體區域的寬度為2mm,間距為4mm,且膠體乳液之基重為30g/m2。且,吸收性物品No.1-1之頂部薄片為基重:25g/m2之透氣不織布(以下有時記作「不織布A」)。 2 parts of SEPS (styrene content: 20% by mass, weight average molecular weight: about 260,000) (hereinafter sometimes referred to as "SEPS-1") and SEBS (styrene content: 31% by mass, weight average molecular weight: about 16 10,000) (hereinafter sometimes referred to as "SEBS-2") 5 parts added to PARLEAM 6 heated to about 140 ° C (made by Nippon Oil Co., Ltd., by copolymerization of flowing isoalkanes, isobutylene and n-butene, followed by addition Branched hydrocarbon formed by hydrogen formation, degree of polymerization: about 5 to about 10, weight average molecular weight: about 330) 90 parts with eucalyptus oil (SHW-100cs, dimethyl polyoxane, manufactured by Dow Corning Toray Co., Ltd., 25 In a mixture of 3 parts of the dynamic viscosity at ° C of 100 mm 2 /s), the mixture was mixed for 5 hours while stirring to form a mixture, as shown in Fig. 1, applied to the skin of the top sheet of the absorbent article. On the contact area, the absorbent article No. 1-1 was obtained. In the absorbent article No. 1-1, the width of the colloidal region was 2 mm, the pitch was 4 mm, and the basis weight of the colloidal emulsion was 30 g/m 2 . Further, the top sheet of the absorbent article No. 1-1 was a breathable nonwoven fabric having a basis weight of 25 g/m 2 (hereinafter referred to as "nonwoven fabric A").

將膠體乳液之基重以及吸收性物品之頂部薄片變更成如表2所示以外,其餘與吸收性物品No.1-1相同,得到吸收性物品No.1-2以及1-3。且,吸收性物品No.1-2以及1-3之頂部薄片為基重:27g/m2之透氣不織布(以下有時記作「不織布B」)。 The basis weight of the colloidal emulsion and the top sheet of the absorbent article were changed to the same as those of the absorbent article No. 1-1 except that the top sheet of the absorbent article was changed to obtain absorbent articles No. 1-2 and 1-3. Further, the top sheets of the absorbent articles No. 1-2 and 1-3 are air-permeable nonwoven fabrics having a basis weight of 27 g/m 2 (hereinafter referred to as "non-woven fabric B").

將膠體乳液之調配以及基重變更成如表2所示以外,其餘與吸收性物品No.1-1相同,得到吸收性物品No.1-4。 The blending and the basis weight of the colloidal emulsion were changed to those shown in Table 2, and the absorbent article No. 1-4 was obtained in the same manner as in the absorbent article No. 1-1.

將膠體乳液之基重以及塗布圖形變更成如表2所示以外,其餘與吸收性物品No.1-1相同,得到吸收性物品No.1-5(比較用試料)以及1-6(比較用試料)。 The basis weight of the colloidal emulsion and the coating pattern were changed as shown in Table 2, and the same as the absorbent article No. 1-1, the absorbent article No. 1-5 (comparative sample) and 1-6 (comparative) were obtained. Use the sample).

將沒有塗布膠體乳液之試料作為吸收性物品No.1-7 (比較用試料)以及1-8(比較用試料)使用。 A sample without a coated colloidal emulsion was used as the absorbent article No. 1-7 (Comparative sample) and 1-8 (comparative sample) are used.

[水接觸角] [water contact angle]

針對吸收性物品No.1-1~1-8評估水接觸角。整理其結果並表示於表2。 The water contact angle was evaluated for the absorbent articles No. 1-1 to 1-8. The results are compiled and shown in Table 2.

[吸收體移行速度以及再濕性] [Absorber migration speed and rewet]

針對吸收性物品No.1-1~1-8,如以下所述測定吸收體移行速度以及再濕性。 With respect to the absorbent articles No. 1-1 to 1-8, the absorbent body migration speed and rewet property were measured as described below.

在吸收性物品之頂部薄片上放置丙烯製的圓筒(外徑60mm,內徑55mm,55g),在上述圓筒內使用滴下漏斗,將人工尿(將尿素200g、氯化鈉80g、硫酸鎂8g、氯化鈣3g以及色素:藍色1號約1g溶解於離子交換水10L中所調製)80mL以8mL/秒之速度滴下(第1次的滴下)。 Place a propylene cylinder on the top sheet of the absorbent article (outer diameter 60mm) , inner diameter 55mm 55g), using a dropping funnel in the above-mentioned cylinder, artificial urine (200 g of urea, 80 g of sodium chloride, 8 g of magnesium sulfate, 3 g of calcium chloride, and about 1 g of dye: blue No. 1 are dissolved in 10 L of ion-exchanged water) 80 mL of the prepared solution was dropped at a rate of 8 mL/second (the first drop).

測定在圓筒內滴下人工尿開始至滯留在圓筒內的人工尿消失為止的時間,作為「吸收體移行速度」。接著,圓筒內的人工尿消失之後,隨即將丙烯製的圓筒移開,自第1次的滴下開始5分鐘後,在滴下人工尿之處,重疊放置濾紙(ADVANTEC東洋股份公司,定性濾紙No.2,100mm×100mm)50g份量,在其上方放置荷重置壓力成為35g/cm2。3分鐘後,取出上述濾紙,根據以下式算出「再濕量」。 The time from when the artificial urine was dropped in the cylinder until the artificial urine remaining in the cylinder disappeared was measured as the "absorbent migration speed". Then, after the artificial urine in the cylinder disappeared, the acrylic cylinder was removed, and 5 minutes after the first dripping, the filter paper was placed at the place where the artificial urine was dropped (ADVANTEC Toyo Co., Ltd., qualitative filter paper) No. 2, 100 mm × 100 mm) A 50 g portion, and a load reset pressure was placed thereon to be 35 g/cm 2 . After 3 minutes, the filter paper was taken out, and the "rewetting amount" was calculated according to the following formula.

再濕量(g)=試驗後之濾紙質量(g)-當初之濾紙質量(g) Rewetting amount (g) = quality of filter paper after test (g) - quality of original filter paper (g)

第1次的滴下開始10分鐘後,重複與第1次相同的操作,實施第2次的滴下。 Ten minutes after the start of the first drop, the same operation as in the first time was repeated, and the second drop was performed.

統整第2次的滴下中之再濕量與第2次的滴下中之吸收體移行速度,並表示於表2。 The rewetting amount in the second dropping and the moving speed of the absorbent in the second dropping were adjusted and shown in Table 2.

得知吸收性物品No.1-1~1-4相較於吸收性物品No.1-5~1-8,再濕率較低且再濕性較優異。 It was found that the absorbent articles No. 1-1 to 1-4 were lower in rewetting rate and more excellent in rewet than the absorbent articles No. 1-5 to 1-8.

[例2] [Example 2]

將SEEPS(kuraray股份公司製,Septon4055,苯乙烯含量:30質量%,重量平均分子量:約25萬)(以下有時省略成「SEEPS-2」)2份添加於加熱至約140℃之PARLEAM EX(日油股份公司製,藉由共聚合流動異烷烴、異丁烯以及n-丁烯,接著加成氫所生成之分支狀烴,在37.8℃下的動力黏度為10mm2/s)98份中,藉由一邊將此等攪拌5小時一邊進行混合,生成混合物,並將該混合物注入直徑40mm的圓筒形容器至高度為8mm為止,接著將混合物冷卻,藉此得到直徑40mm且高度8mm之圓筒形膠體乳液No.2-1。 SEEPS (Septon 4055, manufactured by Kuraray Co., Ltd., styrene content: 30% by mass, weight average molecular weight: about 250,000) (hereinafter sometimes omitted "SEEPS-2") was added to PARLEAM EX heated to about 140 °C. (manufactured by Nippon Oil Co., Ltd., by copolymerizing a flow of isoparaffin, isobutylene, and n-butene, followed by addition of hydrogen to form a branched hydrocarbon, a dynamic viscosity at 107.8 ° C of 10 mm 2 /s) 98 parts, The mixture was mixed while stirring for 5 hours to form a mixture, and the mixture was poured into a cylindrical container having a diameter of 40 mm to a height of 8 mm, and then the mixture was cooled, thereby obtaining a cylinder having a diameter of 40 mm and a height of 8 mm. Colloidal emulsion No. 2-1.

將3份SEPS-1添加於加熱至約140℃之PARLEAM EX92份與矽油5份的混合物中,藉由將此等一邊攪拌5小時一邊混合,生成混合物,將該後來之產物注入直徑40mm之圓筒形容器中至高度為8mm為止,接著將混合物冷卻,藉此得到直徑40mm且高度8mm之圓筒形膠體乳液No.2-6。 3 parts of SEPS-1 was added to a mixture of 92 parts of PARLEAM EX heated to about 140 ° C and 5 parts of eucalyptus oil, and the mixture was stirred while stirring for 5 hours to form a mixture, and the subsequent product was injected into a circle having a diameter of 40 mm. The cylindrical container was allowed to have a height of 8 mm, and then the mixture was cooled, whereby a cylindrical colloidal emulsion No. 2-6 having a diameter of 40 mm and a height of 8 mm was obtained.

除了將調配變更成表3所示以外,其餘與膠體乳液No.2-1或膠體乳液No.2-6相同,得到膠體乳液No.2-2~2-5以及No.2-7~2-20。 The colloidal emulsion No. 2-2 to 2-5 and No. 2-7 to 2 were obtained in the same manner as the colloidal emulsion No. 2-1 or the colloidal emulsion No. 2-6 except that the blending was changed to that shown in Table 3. -20.

且,表3中所記載之化合物的概要如以下所述,但關 於別處所說明者,則省略說明。 Further, the outlines of the compounds described in Table 3 are as follows, but If it is described elsewhere, the description will be omitted.

且,評估膠體乳液No.2-1~2-20之50%變形時的壓縮應力與靜磨擦係數。統整並表示於表3。 Further, the compressive stress and the static friction coefficient at 50% deformation of the colloidal emulsion No. 2-1 to 2-20 were evaluated. Consolidated and shown in Table 3.

.SEEPS-1: . SEEPS-1:

苯乙烯含量:30質量%,重量平均分子量:約11萬 Styrene content: 30% by mass, weight average molecular weight: about 110,000

.SEBS-1: . SEBS-1:

苯乙烯含量:30質量%,重量平均分子量:約11萬 Styrene content: 30% by mass, weight average molecular weight: about 110,000

.SEBS-2: . SEBS-2:

苯乙烯含量:31質量%,重量平均分子量:約16萬 Styrene content: 31% by mass, weight average molecular weight: about 160,000

.SEBS-3: . SEBS-3:

苯乙烯含量:33質量%,重量平均分子量:約29萬 Styrene content: 33% by mass, weight average molecular weight: about 290,000

[例3] [Example 3]

根據下述表4所記載之調配以外,再根據製造例1之膠體乳液No.2-6的順序,得到直徑40mm且高度8mm之圓筒形膠體乳液No.3-1~3-4。 The cylindrical colloidal emulsion Nos. 3-1 to 3-4 having a diameter of 40 mm and a height of 8 mm were obtained in the order of the colloidal emulsion No. 2-6 of Production Example 1 in addition to the preparation described in the following Table 4.

且,表4所記載之化合物的概要如以下所述。 Further, the outlines of the compounds described in Table 4 are as follows.

.NONION OP-80R: . NONION OP-80R:

日油股份公司製,單十八烯酸山梨醇酐 Made from Nippon Oil Co., Ltd., oleic acid sorbitan

.KP-561P . KP-561P

信越化學工業股份公司製,丙烯酸酯/丙烯酸硬脂醯/丙烯酸二甲聚矽氧烷共聚合物 Shin-Etsu Chemical Industry Co., Ltd., acrylate/acrylic acid stearin/dimethyl methacrylate copolymer

測定膠體乳液No.3-1~3-4之靜磨擦係數。統整結果並表示於表4。 The static friction coefficient of the colloidal emulsion No. 3-1 to 3-4 was measured. The results are consolidated and shown in Table 4.

[例4] [Example 4]

根據下述表5所記載之調配,且將3g的量注入內徑47mm的玻璃製器皿內以外,根據製造例2之膠體乳液No.2-1或No.2-6的順序,得到膠體乳液No.4-1~4-4。 A colloidal emulsion was obtained according to the order of the colloidal emulsion No. 2-1 or No. 2-6 of Production Example 2, except that the amount of 3 g was injected into a glass vessel having an inner diameter of 47 mm according to the formulation described in the following Table 5. No.4-1~4-4.

根據引證1之實施例4A,準備包含鑛油65質量%與鯨蠟硬脂醇35質量%之乳液組成物,將3g的量注入內徑47mm的玻璃製器皿內,準備膠體乳液No.4-5(比較例)。 According to Example 4A of Citation 1, an emulsion composition containing 65% by mass of mineral oil and 35% by mass of cetearyl alcohol was prepared, and an amount of 3 g was poured into a glass vessel having an inner diameter of 47 mm to prepare a colloidal emulsion No. 4- 5 (comparative example).

將膠體乳液No.4-1~4-5靜置於35℃或20℃之恆溫室中30分鐘,接著,在各膠體乳液上放置測定質量的3cm×3cm濾紙,在其上方乘載200g的荷重,1分鐘之後將荷重去除,測定濾紙質量的變化。將結果表示於表5。 The colloidal emulsion No. 4-1 to 4-5 was statically placed in a thermostatic chamber at 35 ° C or 20 ° C for 30 minutes, and then a measuring mass of 3 cm × 3 cm filter paper was placed on each colloidal emulsion, and 200 g of the filter paper was placed thereon. The load was removed, and the load was removed after 1 minute, and the change in the quality of the filter paper was measured. The results are shown in Table 5.

由表5可明顯確認到膠體乳液No.4-1~4-4不會隨著溫度變化,會釋放出一定量的乳液,並且指出在寒冷~溫暖的區域中,也能夠同樣地繼續釋放乳液。 It can be clearly seen from Table 5 that the colloidal emulsion No. 4-1 to 4-4 does not release a certain amount of emulsion with temperature change, and it is pointed out that the emulsion can be continuously released in a cold to warm region. .

另一方面,也得知膠體乳液No.4-5(比較例)在溫度較低的情況之下,難以釋放出乳液。 On the other hand, it was also found that the colloidal emulsion No. 4-5 (comparative example) was difficult to release the emulsion at a low temperature.

本發明為關於以下J1~J11。 The present invention relates to the following J1 to J11.

[J1] [J1]

一種吸收性物品,其係具備:具有肌膚接觸區域以及肌膚不接觸區域之液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層、與膠體乳液,並具有厚度方向之吸收性物品,且上述膠體乳液中包含作為膠體化劑之苯乙烯系彈性體、與作為乳液之烴,且上述液體透過性層在上述肌膚接觸區域中具有:具有上述膠體乳液之複數個膠體區域、與不具有膠體乳液之非膠體區域,且在上述肌膚不接觸區域中具有:分別與上述複數之膠體區域以及上述非膠體區域在上述厚度方向重複之複數個膠體區域重複域以及非膠體區域重複域,上述複數個膠體區域中,在互相相鄰的2個膠體區域之至少一部分中,互相相鄰的2個膠體區域之互相最近的點之2個鄰接點、與在該2個鄰接點的中間且存在上述非膠體區域之中間點、與上述2個鄰接點之在上述厚度方向重複且存在於上述膠體區域重複域之2個鄰接點相當點、與上述中間點之在上述厚度方向重複且存在於上述非膠體 區域重複域之中間點相當點滿足以下i)~iii)之關係i)2個鄰接點的水接觸角,其雙方都在85°以上、ii)上述中間點中之水接觸角比上述2個鄰接點相當點中之水接觸角大、以及iii)上述中間點之水接觸角與上述中間點相當點之水接觸角的差比-3(°)大。 An absorbent article comprising: a liquid permeable layer having a skin contact region and a skin non-contact region; an absorbing layer between the liquid permeable layer and the liquid permeable layer and the liquid opaque layer; a colloidal emulsion having an absorbent article in a thickness direction, wherein the colloidal emulsion contains a styrene-based elastomer as a colloidalizing agent and a hydrocarbon as an emulsion, and the liquid-permeable layer has the skin contact region: a plurality of colloidal regions of the colloidal emulsion and a non-colloidal region having no colloidal emulsion, and having a plurality of colloids respectively overlapping the plurality of colloidal regions and the non-colloidal region in the thickness direction in the non-contact region of the skin a region repeating domain and a non-colloidal region repeating region, wherein in the at least one of the two colloidal regions adjacent to each other, at least two adjacent points of the two colloidal regions adjacent to each other, And an intermediate point between the two adjacent points and the non-colloidal region, and the two adjacent points Repeat and is present in two adjacent points is quite point repeat domains of the colloidal region in the thickness direction, and is present in the non-repeating colloid in the thickness direction of the intermediate point of the The intermediate point of the region repeating region satisfies the following relationship i) to iii) i) the water contact angle of the two adjacent points, both of which are at 85° or more, ii) the water contact angle in the intermediate point is higher than the above two The water contact angle in the point where the adjacent point is large is large, and iii) the difference between the water contact angle of the intermediate point and the water contact angle of the point corresponding to the intermediate point is larger than -3 (°).

[J2] [J2]

如J1之吸收性物品,其中,上述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 An absorbent article according to J1, wherein the colloidal emulsion has a compressive stress at 50% deformation of 1 to 100 kPa.

[J3] [J3]

如J1或J2之吸收性物品,其中,上述膠體乳液中,基於此等之合計100質量份,分別以1~30質量份以及70~99質量份之比率包含上述膠體化劑以及乳液。 In the above-mentioned colloidal emulsion, the colloidal agent and the emulsion are contained in a ratio of 1 to 30 parts by mass and 70 to 99 parts by mass, respectively, based on 100 parts by mass of the total of the above-mentioned colloidal emulsions.

[J4] [J4]

如J1~J3中任一項之吸收性物品,其中,上述聚苯乙烯系嵌段包含兩末端之聚苯乙烯嵌段與其之間的聚烯烴嵌段。 The absorbent article according to any one of J1 to J3, wherein the polystyrene block comprises a polyolefin block at both ends and a polyolefin block therebetween.

[J5] [J5]

如J1~J4中任一項之吸收性物品,其中,上述聚苯乙烯系嵌段包含10~50質量%之聚苯乙烯嵌段與50~90質量%之聚烯烴嵌段。 The absorbent article according to any one of the above aspects, wherein the polystyrene block comprises 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block.

[J6] [J6]

如J1~J5中任一項之吸收性物品,其中,上述苯乙烯系彈性體具有5,000~500,000之重量平均分子量。 The absorbent article according to any one of the above-mentioned, wherein the styrene-based elastomer has a weight average molecular weight of 5,000 to 500,000.

[J7] [J7]

如J1~J6中任一項之吸收性物品,其中,上述膠體乳液進一步包含抗磨劑。 The absorbent article of any one of J1 to J6, wherein the above colloidal emulsion further comprises an antiwear agent.

[J8] [J8]

如J1~J7中任一項之吸收性物品,其中,上述膠體乳液具有0.01~1.00之靜磨擦係數。 The absorbent article according to any one of J1 to J7, wherein the colloidal emulsion has a static friction coefficient of 0.01 to 1.00.

[J9] [J9]

如J1~J8中任一項之吸收性物品,其中,進一步包含作為上述乳液之體液滑性賦予劑,該體液滑性賦予劑具有超過0.00且0.60以下之IOB、與在40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 The absorbent article according to any one of the aspects of the present invention, further comprising the body fluid slip imparting agent as the emulsion, wherein the body fluid slip imparting agent has an IOB of more than 0.00 and 0.60 or less, and a 0.01% at 40 ° C. The dynamic viscosity of 80 mm 2 /s, the water holding ratio of 0.01 to 4.0% by mass, and the weight average molecular weight of less than 1,000.

[J10] [J10]

如J1~J9中任一項之吸收性物品,其中,上述膠體乳液在上述液體透過性層之肌膚接觸區域中被配置成線狀或點狀。 The absorbent article according to any one of the above aspects, wherein the colloidal emulsion is disposed in a line shape or a dot shape in a skin contact region of the liquid permeable layer.

[J11] [J11]

如J1~J10中任一項之吸收性物品,其係拋棄式尿布、生理用衛生棉或護墊。 An absorbent article according to any one of J1 to J10, which is a disposable diaper, a sanitary napkin or a pad.

Claims (11)

一種吸收性物品,其特徵為具備:具有肌膚接觸區域以及肌膚不接觸區域之液體透過性層、與液體不透過性層、與前述液體透過性層以及液體不透過性層之間的吸收層、與膠體乳液,且具有厚度方向之吸收性物品,且前述膠體乳液包含作為膠體化劑之苯乙烯系彈性體、與作為乳液之烴,前述液體透過性層中,在前述肌膚接觸區域中具有:具有前述膠體乳液之複數個膠體區域、與不具有膠體乳液之非膠體區域,且前述肌膚不接觸區域中具有分別與前述複數之膠體區域以及前述非膠體區域在前述厚度方向上重複之複數個膠體區域重複域以及非膠體區域重複域,前述複數個膠體區域當中,互相相鄰的2個膠體區域的至少一部分中,互相相鄰的2個膠體區域之互相最近的點之2個鄰接點、與在該2個鄰接點的中間,且存在於前述非膠體區域之中間點、與前述2個鄰接點之在前述厚度方向上重複且存在於前述膠體區域重複域的2個鄰接點相當點、與前述中間點之在前述厚度方向上重複且存在於前述非膠體區域重複域的中間點相當點具有以下i)~iii)之關係i)2個鄰接點的水接觸角,其雙方都在85°以上、ii)前述中間點之水接觸角比前述2個鄰接點相當點之水接觸角大、以及iii)前述中間點之水接觸角與前述中間點相當點之水 接觸角的差比-3(°)大。 An absorbent article comprising: a liquid permeable layer having a skin contact region and a skin non-contact region; and a liquid impervious layer; and an absorbing layer between the liquid permeable layer and the liquid opaque layer; And a colloidal emulsion having an absorbent article having a thickness direction, wherein the colloidal emulsion comprises a styrene-based elastomer as a colloidizing agent and a hydrocarbon as an emulsion, and the liquid-permeable layer has a skin contact region in the skin contact region: a plurality of colloidal regions having the colloidal emulsion, and a non-colloidal region having no colloidal emulsion, and the plurality of colloids having the colloidal region and the non-colloidal region respectively repeating in the thickness direction in the non-contact region of the skin a region repeating domain and a non-colloidal region repeating region, wherein at least a part of the two colloidal regions adjacent to each other among the plurality of colloidal regions, two adjacent points of the two adjacent colloidal regions are adjacent to each other In the middle of the two adjacent points, and present in the middle point of the non-colloidal region, and the two The two adjacent points of the contact point which are repeated in the thickness direction and exist in the repeating domain of the colloid region are equivalent to the intermediate point of the intermediate point which is repeated in the thickness direction and which exists in the repeating domain of the non-colloidal region. Relationship between i) and iii) i) water contact angles of two adjacent points, both of which are 85° or more, ii) the water contact angle of the intermediate point is larger than the water contact angle of the two adjacent points And iii) the water contact angle of the aforementioned intermediate point is equal to the water of the aforementioned intermediate point The difference in contact angle is larger than -3 (°). 如請求項1之吸收性物品,其中,前述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 The absorbent article according to claim 1, wherein the colloidal emulsion has a compressive stress at 50% deformation of 1 to 100 kPa. 如請求項1或2之吸收性物品,其中,前述膠體乳液中,基於此等合計100質量份,分別以1~30質量份以及70~99質量份之比率包含前述膠體化劑以及乳液。 The absorbent article according to claim 1 or 2, wherein the colloidal emulsion contains the colloidalizing agent and the emulsion in a ratio of 1 to 30 parts by mass and 70 to 99 parts by mass based on 100 parts by mass in total. 如請求項1或2之吸收性物品,其中,前述聚苯乙烯系嵌段包含兩末端之聚苯乙烯嵌段、與在其之間的聚烯烴嵌段。 The absorbent article of claim 1 or 2, wherein the polystyrene block comprises a polystyrene block at both ends and a polyolefin block therebetween. 如請求項1或2之吸收性物品,其中,前述聚苯乙烯系嵌段包含10~50質量%的聚苯乙烯嵌段、與50~90質量%的聚烯烴嵌段。 The absorbent article according to claim 1 or 2, wherein the polystyrene block comprises 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block. 如請求項1或2之吸收性物品,其中,前述苯乙烯系彈性體具有5,000~500,000之重量平均分子量。 The absorbent article of claim 1 or 2, wherein the styrene-based elastomer has a weight average molecular weight of 5,000 to 500,000. 如請求項1或2之吸收性物品,其中,前述膠體乳液進一步包含抗磨劑。 The absorbent article of claim 1 or 2, wherein the aforementioned colloidal emulsion further comprises an anti-wear agent. 如請求項1或2之吸收性物品,其中,前述膠體乳液具有0.01~1.00之靜磨擦係數。 The absorbent article of claim 1 or 2, wherein the aforementioned colloidal emulsion has a static friction coefficient of 0.01 to 1.00. 如請求項1或2之吸收性物品,其中,進一步包含作為前述乳液之體液滑性賦予劑,該體液滑性賦予劑具有超過0.00且0.60以下之IOB、與40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 The absorbent article according to claim 1 or 2, further comprising a body fluid slip imparting agent as the emulsion, the body fluid slip imparting agent having an IOB of more than 0.00 and 0.60 or less, and 0.01 to 80 mm 2 at 40 ° C / The dynamic viscosity of s, the water holding ratio of 0.01 to 4.0% by mass, and the weight average molecular weight of less than 1,000. 如請求項1或2之吸收性物品,其中,前述膠體 乳液在前述液體透過性層之肌膚接觸區域中配置成線狀或點狀。 The absorbent article of claim 1 or 2, wherein the aforementioned colloid The emulsion is disposed in a line shape or a dot shape in the skin contact region of the liquid permeable layer. 如請求項1或2之吸收性物品,其係拋棄式尿布、生理用衛生棉或護墊。 The absorbent article of claim 1 or 2, which is a disposable diaper, a sanitary napkin or a pad.
TW104118140A 2014-06-06 2015-06-04 Absorbent article TWI648036B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-117924 2014-06-06
JP2014117924A JP6415119B2 (en) 2014-06-06 2014-06-06 Absorbent articles

Publications (2)

Publication Number Publication Date
TW201545726A TW201545726A (en) 2015-12-16
TWI648036B true TWI648036B (en) 2019-01-21

Family

ID=54766457

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104118140A TWI648036B (en) 2014-06-06 2015-06-04 Absorbent article

Country Status (8)

Country Link
JP (1) JP6415119B2 (en)
KR (1) KR102112385B1 (en)
CN (1) CN106413649B (en)
AU (1) AU2015269952B2 (en)
BR (1) BR112016028486A2 (en)
MY (1) MY182359A (en)
TW (1) TWI648036B (en)
WO (1) WO2015186376A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436038B1 (en) * 2001-12-19 2004-06-12 씨제이 주식회사 Manufacturing method of uncooked food and uncooked food manufactured thereby
WO2017209010A1 (en) * 2016-05-31 2017-12-07 花王株式会社 Absorbent article
RU2753916C2 (en) * 2016-05-31 2021-08-24 Као Корпорейшн Non-woven material
RU2735533C2 (en) * 2016-05-31 2020-11-03 Као Корпорейшн Non-woven material
WO2017209006A1 (en) * 2016-05-31 2017-12-07 花王株式会社 Nonwoven long-fiber fabric
WO2020213733A1 (en) * 2019-04-19 2020-10-22 ユニ・チャーム株式会社 Absorbent article
JP7170579B2 (en) * 2019-04-19 2022-11-14 ユニ・チャーム株式会社 skin care sheet
CN114795670A (en) * 2022-03-28 2022-07-29 福建省诺华卫生用品有限公司 Preparation method of composite surface layer paper diaper
TWI794124B (en) * 2022-07-04 2023-02-21 富堡工業股份有限公司 Diapers with Indium Tin Oxide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534089A (en) * 2001-07-03 2004-11-11 ザ プロクター アンド ギャンブル カンパニー Film-forming compositions for protecting skin from body fluids and articles made therefrom

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2974693B2 (en) * 1988-09-06 1999-11-10 花王株式会社 Surface material for absorbent articles
US5643588A (en) 1994-11-28 1997-07-01 The Procter & Gamble Company Diaper having a lotioned topsheet
US20040033750A1 (en) * 1998-06-12 2004-02-19 Everett Rob D Layered absorbent structure with a heterogeneous layer region
KR100476909B1 (en) 1999-05-19 2005-03-18 더 프록터 앤드 갬블 캄파니 Absorbent article with skin care composition
US6626961B1 (en) * 2000-04-27 2003-09-30 Kimberly-Clark Worldwide, Inc. Nonwovens modified with petrolatum
US20050154362A1 (en) * 2001-10-01 2005-07-14 Raphael Warren Sanitary napkins with hydrophobic lotion and apertured topsheet
US20030082219A1 (en) * 2001-10-01 2003-05-01 The Procter & Gamble Company Skin care compositions comprising low concentrations of skin treatment agents
US20040170589A1 (en) 2001-10-01 2004-09-02 Gatto Joseph Anthony Sanitary napkins with hydrophobic lotions
US20050129651A1 (en) 2001-10-01 2005-06-16 Gatto Joseph A. Sanitary napkins with hydrophobic lotions
US20060062816A1 (en) * 2001-10-01 2006-03-23 Gatto Joseph A Sanitary napkins with hydrophobic lotions
US7060867B2 (en) * 2002-11-27 2006-06-13 Kimberly-Clark Worldwide, Inc. Absorbent article with a body facing liner having discretely placed lotion deposits
US20060069370A1 (en) 2004-09-30 2006-03-30 Kimberly-Clark Worldwide, Inc. Absorbent article having a liner with areas that prevent lotion and adhesive migration
US8211078B2 (en) 2005-02-17 2012-07-03 The Procter And Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
AR065378A1 (en) 2007-02-16 2009-06-03 Procter & Gamble ABSORBENT ARTICLE WITH LOTION THAT INCLUDES A POLYPROPYLENE GLYCOL MATERIAL
JP6265586B2 (en) * 2012-02-29 2018-01-24 ユニ・チャーム株式会社 Absorbent articles
JP6062199B2 (en) * 2012-09-28 2017-01-18 ユニ・チャーム株式会社 Absorbent articles
CN103417337A (en) * 2013-07-17 2013-12-04 厦门延江工贸有限公司 Non-woven fabric

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534089A (en) * 2001-07-03 2004-11-11 ザ プロクター アンド ギャンブル カンパニー Film-forming compositions for protecting skin from body fluids and articles made therefrom

Also Published As

Publication number Publication date
CN106413649A (en) 2017-02-15
TW201545726A (en) 2015-12-16
BR112016028486A2 (en) 2017-08-22
KR102112385B1 (en) 2020-06-04
WO2015186376A1 (en) 2015-12-10
KR20170016321A (en) 2017-02-13
AU2015269952A1 (en) 2016-12-08
JP6415119B2 (en) 2018-10-31
CN106413649B (en) 2019-07-19
JP2015229071A (en) 2015-12-21
MY182359A (en) 2021-01-20
AU2015269952B2 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
TWI648036B (en) Absorbent article
TWI654968B (en) Absorbent article
TWI580409B (en) Non-woven and absorbent articles
TWI577352B (en) Absorbent items
TWI600413B (en) Absorbent article
TWI634878B (en) Absorbent article
TWI577359B (en) Absorbent items
JP6695397B2 (en) Absorbent article
TWI573576B (en) Absorbent items
JP7101636B2 (en) Use of absorbent articles, cleaning sheets, and wipe improvers
JP7272945B2 (en) Use of absorbent articles, cleaning sheets, and wiping-enhancing compositions
TW201436776A (en) Absorbent article
WO2024029375A1 (en) Absorbent article
JP6618451B2 (en) Absorbent articles, blood modifiers and use of blood modifiers
JP2023025797A (en) absorbent article

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees